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ABSTRACT 
 
     Neurodegenerative diseases like Alzheimer’s disease (AD), Parkinson’s 
disease (PD), and amyotrophic lateral sclerosis (ALS), include the progressive loss of 
structure and function of neurons leading to neuronal death. All of these diseases are 
fatal, as there is no cure for them. The causes of these diseases are unknown; however, 
there are many proposed mechanisms that lead to neurodegenerative diseases. Oxidative 
stress is the leading cause of cell death in neurodegenerative diseases, in addition to other 
mechanisms including endoplasmic reticulum stress, proteasome inhibition, nitrosative 
stress, inflammation and excitotoxicity. More understanding of the death mechanisms at 
work in neurodegeneration is necessary to find ways to block those mechanisms in order 
to slow or stop the progress of these disorders.  Interest in nutraceutical compounds has 
increased recently because of the discovery their bioactive properties. Many studies have 
suggested that nutraceutical compounds have the ability to inhibit the different death 
pathways.   
       In this study, we investigated the neuroprotective efficacy of seven natural 
compounds in several in vitro models of cell death. In primary cultured rat cerebellar 
granule neurons (CGNs), pre-incubation with caffeic acid, which is abundant in green 
coffee beans, completely protected against cell death induced by several mechanisms. 
Caffeic acid protected against effects of sodium nitroprusside (SNP), an agent that 
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induces nitrosative stress, glutamate /glycine which prompts excitotoxicity, hydrogen 
peroxide, an inducer of oxidative stress, proteasome inhibitors, 5K medium that induces 
caspase-dependent apoptosis, and endoplasmic reticulum stressors.  Furthermore, caffeic 
acid reduced inflammation induced by lipopolysaccharides in BV2 mouse microglial cell 
line. Chlorogenic acid and ferulic acid protected from one agent. Chlorogenic acid only 
protected CGNs from SNP; however, ferulic acid protected the CGNs from glutamate 
toxicity. Quinic acid did not protect from any agents or stressors. Rosmarinic acid 
protected the CGNs against glutamate toxicity, and carnosic acid protected the cells from 
5K medium that typically induces apoptosis. Both rosmarinic acid and carnosic acid 
protected the cells from SNP and subsequent nitrosative stress.  We further suggeste that 
carnosic acid protects CGNs from caspase-dependent apoptosis through activation of the 
phosphoinositide 3-kinase (PI3K) pro-survival pathway. Pyrroloquinoline quinone (PQQ) 
also showed a significant protection against oxidative stress typically induced by 
hydrogen peroxide and copper chloride. The cumulative data suggest that nutraceutical 
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CHAPTER ONE: INTRODUCTION  
 
1.1. Mechanisms of neurodegenerative diseases  
Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s 
disease (PD), and amyotrophic lateral sclerosis (ALS) are progressive nervous system 
disorders defined by loss of neurons consequent to multiple factors including, mis-folding 
and dysfunctional trafficking of proteins, mitochondrial dysfunction, excitotoxicity, and 
oxidative stress (Ferraiuolo et al., 2011; Dawson and Dawson 2003; Chakrabarti and 
Mohanakumar, 2016). Neurodegenerative diseases typically target elderly people 
between 50-70 years old. While many neurodegenerative movement disorders cause 
muscle atrophy, resting tremor, and, postural instability (Thomas and Beal, 2007; 
Ferraiuolo et al., 2011), it is also common for many of these disorders to affect patients 
mentally by disrupting cognitive function and causing loss memory (Anand et al., 2013).  
Nonetheless, the underlying cause and mechanism of neuronal cell death remains largely 
unknown. For instance, in the case of ALS, epidemiological studies have revealed that 
the disease is caused by a familial mutation in only 5-10 % of patients, while the majority 
of patients harbor the sporadic ALS with no known genetic component (Thomas and 
Beal, 2007; Ferraiuolo et al., 2011; Anand et al., 2013). It is important to unravel the 
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precise signaling pathways and etiology that underlie fatal neurodegenerative diseases as 
only few medications have been approved by US Food and Drug Administration (FDA). 
Further, the medications that are currently FDA-approved merely help to decrease the 
severity of symptoms but do not cure the underlying cause of the disease (Kumar et al., 
2015). Furthermore, many of these drugs are not very effective, and a number of patients 
do not respond to treatment.   Although each disease has its own molecular hallmark and 
unique etiology, it is intriguing that disruption of similar cellular processes (e.g. oxidative 
stress, inflammation, etc.) is believed to be common to several neurodegenerative 
diseases. Thus, more efforts must be made to discover drugs that target several common 
molecular pathways that underlie these diseases. Further understanding of the 
pathological mechanisms contributing to neuronal cell death may be an encouraging 
method to identify novel therapeutics for the treatment of these devastating 
neurodegenerative disorders.    
1.1.1. Apoptosis.   
     Apoptosis, or programmed cell death (PCD), is a major cell death mechanism. 
Apoptosis is characterized by cytoplasmic condensation, nuclear fragmentation, cell 
rounding, cytoskeletal collapse, and membrane blebbing (Ghavami et al., 2014). 
Disruption of cellular survival and death pathways such as apoptosis are believed to play 
a critical role in neurodegenerative diseases. At the cellular level, the caspase family of 
proteins are the key executioners in apoptosis (Stroh et al., 2002). There are two types of 
caspases: initiator and effector caspases (Ghavami et al., 2014). The initiator caspase 
group includes caspase-8 and caspase-9, both of which are activated by upstream signals. 
Following activation of caspases-8 and caspases-9, the signal is propagated by activation 
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of the downstream effector caspases, caspase-3 and caspase-7 (Los et al., 1995; Fuchs 
and Steller, 2011: Ghavami et al., 2009b). External apoptosis is mediated by cell death 
molecules like TRAIL, TNFα, and Fas, which activate caspase -8. However, caspase-9 is 
activated by internal stress such as starvation and mitochondrial dysfunction (Hashemi et 
al., 2013; Los et al., 1995; Fuchs and Steller, 2011). In response to stress, cytochrome c is 
released from the mitochondria, causing the formation of the apoptosome complex, or the 
caspase-9 activating complex (Fuchs and Steller, 2011).  There are two types of apoptotic 
pathways; the extrinsic apoptotic pathway and the intrinsic apoptotic pathway (Fig. 1.1). 
In the extrinsic pathway, implicated death receptors recruit adaptor molecules to their 
death domain, activate caspase-8, and subsequently activate caspase-7 and caspase-3 to 
cause cell death. In the intrinsic apoptotic pathway, the imbalance in the level of pro-
apoptotic Bcl-2 family members (Bax, Bak, etc.) and anti-apoptotic members (Bcl-2, 
Mcl-1, etc.), results in the formation of Bax/Bak oligomers in the outer mitochondrial 
membrane, which forms a pore to release cytochrome c. To enhance our understanding of 
the intrinsic apoptosis pathway, primary cultures of cerebellar granule neurons (CGNs) 
provide an ideal and commonly used model for this type of study.  These cells survive 
under high extracellular potassium concentrations, and die by apoptosis when cultured in 
a low level of potassium (D’Mello et al., 1993). To study apoptosis, CGNs exposed to 
low concentrations of extracellular K + offer a good in vitro model (Lauritzen et al., 









Figure 1.1. Overview of Apoptotic Pathways. The extrinsic and intrinsic pathways 
illustrate the binding of the death receptor Fas by the death ligand Fas L, activation 
of pro caspases to caspases leading to apoptosis. Cleavage of Bid to t-Bid shows a 
conjunction point between the extrinsic and intrinsic pathway where the inhibition 
of pro-survival proteins (Bcl2/Bcl-Xl) leads to the activation of Bax and Bak. 
Cytochrome c is released from the mitochondria leading to the activation of 











Figure. 1.2. Cerebellar granule neurons (CGNs)-a standard model system in which 
to study apoptosis. A. CGN culture was treated with vehicle (control). B. CGN 
















1.1.2. Oxidative stress. 
Strong scientific evidence suggests that oxidative stress is one of the most 
common known mechanisms contributing to degenerative diseases. Oxidative stress is 
also thought to contribute to aging, which is one of the highest risk factors for 
neurodegenerative diseases. Oxidative stress underlies additional factors that are believed 
to lead to neurodegenerative diseases, such as mitochondrial dysfunction and 
excitotoxicity (Duffy et al., 2011; Rao and Weiss, 2004).  
Free oxygen radicals such as hydroxyl (OH·), superoxide (O2
–·) and nitric oxide 
(NO·), as well as, other reactive oxygen species (ROS) such as hydrogen peroxide 
(H2O2), are produced in our bodies and play an essential role in a variety of critical 
biological processes such as gene transcription (Uttara et al., 2009).  The production of 
ROS is known to be regulated by antioxidants such as glutathione, polyphenols, and 
creatine (Uttara et al., 2009). The balance between ROS production and the availability of 
antioxidants is critical for determining cell fate, as imbalances between the two results in 
oxidative damage to many fundamental molecules (lipid, protein, and DNA), leading to 
oxidative stress and potentially cell death (Fridovich, 1999). Current research suggests 
that oxidative stress may also arise from genetic mutations. For instance, both oxidative 
stress and neuropathology develop in people with hemochromatosis-associated mutations 
(Gordeuk et al., 1992).  As oxidative stress is one of the most common pathological 
mechanisms underlying neurodegenerative disorders, animal models demonstrating key 
characteristics of oxidative stress will be useful to find new therapies for these diseases. 
For instance, one current model treats animals with toxicants that induce oxidative stress 
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(i.e. paraquat) and then observes the effect of this insult.  Another approach to modeling 
oxidative stress is a genetic one.  Transgenic mice that have been manipulated to express 
different genes, like super oxide dismutase 1 (SOD1), super oxidative dismutase 2 
(SOD2), and glutathione peroxide 1 (GPx1), provide a suitable approach to study 
oxidative stress. Moreover, there are a number of genes in Drosophila melanogaster and 
Caenorhabditis elegans have been studied to model the biological effects caused by the 
production of toxic ROS (Melov, 2002).  Each of these model systems is helping to 
unravel the contribution of oxidative stress to neurodegenerative disorders. 
1.1.3. Inflammation.  
    Inflammation is a response caused by pathogenic or irritant stimuli that results 
in the activation of an organism’s defensive response against that stimulation. Acute 
inflammation is inherently protective; however, aberrant inflammation may lead to the 
destruction of the host cell. Strong evidence supports a role for neuroinflammation in 
various neurodegenerative disorders including AD, PD, and ALS.  
 Neuroinflammation is a process that includes activation of glia cells, including 
microglia and astrocytes. Microglia exert a dual role in the progression of 
neurodegenerative diseases, as they have the potential to cause both protection and 
degeneration in the central nervous system (CNS). In the short term, microglia have a 
major role in the inflammatory process, and protect the CNS integrity; however, when 
they are constitutively activated, the morphological characteristics of the cell become 
more phagocytic, and display increased levels of the major histocompatibility complex 
(MHC) antigens that recognize foreign molecules (Hayes et al., 1987).  Microglia also 
produce inflammatory cytokines, which are responsible for enhancing the inflammatory 
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reaction as a protective measure in neurons exposed to an irritant stimulus. However, 
when chronically activated microglia may cause toxicity to neurons. This type of toxicity 
in the CNS is a pathogenic hallmark of several neurodegenerative disorders, and is 
initiated by the production of inflammatory cytokines like IL-1β, TNF-α, and IL-6 (Glass 
et al., 2010). Furthermore, activated microglia can also engulf intact cells, leading to 
neurodegeneration (Glass et al., 2010). Studying the mechanism of neuro-inflammation is 
a critical way to modulate many chronic neurodegenerative disorders linked to this 
mechanism. There are different types of models to study neuro-inflammation including 
viral, drug administration, and genetic models. There are three genetic mouse models of 
Alzheimer’s diseases that are known to cause microgliosis and astrogliosis (activated 
microglia and astrocytes, respectively). These models include APP/PS1, P301S, Tau, and 
Tg2576. Another model of neuro-inflammation is AVV-α-synuclein a common viral 
model of Parkinson’s disease. Administration to mice of the neurotoxin MPTP, is another 
model of Parkinson’s disease used to study the neuro-inflammatory phenotype of this 
disease (Jackson-Lewis and Przedborski, 2007). Lipopolysaccharide administered to 
animals or cultured cells provides another technique to study neuro-inflammation in vitro 
(Lee et al., 2008; Gui et al., 2012). 
1.1.4. Excitotoxicity. 
     Excitotoxicity plays a substantial role in many human diseases such as 
ischemia, trauma, and neurodegenerative disease (Doble, 1999). Excitotoxicity is defined 
as an extreme stimulation of glutamatergic receptors by the excitatory amino acid 
neurotransmitter, glutamic acid. Aberrant stimulation of glutamatergic receptors leads to 
enhanced intracellular calcium elevation (Doble, 1999). As a result of overstimulation of 
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glutamate receptors due to either elevated synaptic levels of glutamate or increased 
sensitivity of the postsynaptic neuron to glutamate, excitotoxicity can trigger neuronal 
cell death (Van Damme et al., 2005).   
Regulation of neuronal glutamate uptake is tightly controlled by a variety of 
diverse mechanisms, which may be implicated in excitotoxicity when glutamate levels 
are dysregulated. For instance, glutamate undergoes reuptake from the synapse by 
glutamate transporter, excitatory amino acid transporter 2 (EAAT2) (Ferraiuolo et al., 
2011).  In addition, α – Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors are also implicated in glutamate excitotoxicity, as they are responsible for much 
of the glutamatergic neurotransmission in the CNS.  The permeability of AMPA 
receptors to calcium is dependent on its GluR2 subunit (Williams et al., 1997), and low 
expression of GluR2 leads to increase Ca 2+ influx and neuronal toxicity (Ferraiuolo et 
al., 2011). N-Methyl-D-aspartate (NMDA) is another glutamate receptor that is believed 
to contribute to both excitotoxicity and thus, neurodegenerative diseases (Zhou et al., 
2013). When NMDA receptors are over activated, excessive neuronal Ca 2+ influx can 
lead to enhanced excitotoxicity and subsequent neuronal cell death (Zhou et al., 2013).  
Given the role of glutamate in regulating neuronal Ca 2+ influx, it is not surprising 
that glutamate excitotoxicity is associated with many other pathways thar have been 
implicated in contributing to the etiology of neurodegenerative disorders. For instance, 
excitotoxicity has been intimately linked to mitochondrial dysfunction, the production of 
toxic ROS and reactive nitrogen species (RNS), loss of mitochondrial membrane 
potential, and apoptotic cell death (Prentice et al 2015; Didier et al., 1996; Finiels et al., 
1995).   
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In order to understand the contribution of excitotoxicity to neurodegeneration, 
several suitable models to study this phenomenon have been designed, such as the lurcher 
mouse. These transgenic mice possess a mutation in an excitatory amino acid receptor 
delta2 (GluRdelta2) that causes excitotoxicity and is a relevant model for excitotoxicity 
cell death (Philips, 1960).  However, more work is needed to test the specific 
involvement of excitotoxicity in the pathogenesis of various neurodegenerative disorders. 
Further, since this mechanism is implicated in various other pathological pathways, it is 
important to develop drugs that block excitotoxicity in order to develop promising 
therapeutics for the treatment neurodegenerative diseases. Interestingly, the only drug 
that is currently approved by the FDA for the treatment of ALS, riluzole, targets 
glutamatergic receptors. However, riluzole only extends the survival of ALS patients a 
mere three months on average (Zoccolella et al., 2007), underscoring the need to 
precisely delineate the involvement of excitotoxicity in the progression of various 
neurodegenerative diseases such as ALS. 
 
1.1.5. Reactive nitrogen species 
     Another possible factor underlining the etiology of neurodegenerative diseases 
is the overproduction of reactive nitrogen species (RNS). For example, the generation of 
nitric oxide may accumulate as a consequence of excessive activation of the 
glutamatergic receptor that increases the entry neuronal Ca 2+ levels. In turn, this leads to 
the activation of neuronal NO synthase (nNOS) (Garthwaite et al., 1988; Bredt et al., 
1991).  In addition to the generation of nNOS, mitochondria have a well-described role in 
generating free radicals during respiration, such as super-oxide anion, which reacts with 
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nitric oxide to form the toxic product peroxynitrite (Beckman et al., 1990; Lipton et al., 
1993). Nitrosative stress has also been demonstrated to contribute to the misfolding of 
proteins, which is has been described in many neurodegenerative diseases (Nakamura and 
Lipton, 2007). Yu and Chuang (1997) established that treatment with sodium 
nitroprusside (SNP), a nitric oxide donor (NO), is suitable model to generate nitrosative 
stress in vitro. Thus, treating cell cultures with specific concentration of SNP is a well-
established model to study nitrosative stress and to understand the pharmacological 
pathways regulating RNS-induced neuronal death. 
1.1.6. Endoplasmic reticulum stress 
      The endoplasmic reticulum (ER) is an essential organelle responsible for 
many cellular processes including the synthesis, folding, modification, and transport of 
proteins (Paschen and Frandsen, 2001; Breckenridge et al., 2003; Rao et al., 2004). 
Nevertheless, under some genetic and environmental conditions, ER stress can lead to 
activation of the unfolded protein response (UPR). It is well documented that activation 
of the UPR can enhance aggregation of misfolded proteins, and subsequently promote 
cell death (Lindholm at el., 2006). The involvement of the UPR to the progression of 
neurodegenerative diseases had been studied in a variety of contexts (Scheper et al., 
2015), and one mechanism by which ER stress may contribute to neuronal cell death is 
through activation of mitochondrial apoptosis (Lindholm et al., 2006). Given this 
important involvement of ER stress is maintaining cellular survival, it is not surprising 
that dysregulation of the UPR is one of the mechanisms that scientists are investigating as 
a promising target for such diseases.  
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To study ER stress, Iwawaki et al. (2004) established the ER stress-activated 
indicator (ERAI) in living cells. In addition, ER stress may also be studied in vitro by 
using different insults like tunicamycin, thapsigargin, and Brefedin A, depending on the 
type of the cell culture. In future studies, these tools will be important for elucidating the 
specific involvement of ER stress in neuronal cell death. 
1.1.7.    Proteasome dysfunction.  
   Every cellular system survives by maintaining a balance between the production 
and the degradation of proteins, which determines on the lifespan of the protein. The 
proteasome is a multi-subunit enzyme that plays a fundamental role in protein 
degradation by degrading all abnormal proteins and expired proteins (Tanaka et al., 
2014). However, dysfunctional proteasomes can lead to protein mis-folding and 
aggregation of abnormally modified proteins, thereby promoting in cell death. MG132 
(carbobenzoxy-Leu-Leu-Ieucinal) is one tool used to study proteasome inhibition. This 
aldehyde can block proteasome activity, causing the cell to switch to other mechanisms 
that play a role in neurodegenerative disorders, including apoptosis and mitochondrial 
dysfunction (Wu et al., 2002; Ling et al., 2003; Qiu et al., 2000). In addition, there are 
several animal models to study proteasome inhibition through ablation of particular 
proteasome subunits, such as deletion of all of the β1i, β2i, and β5i subunits (Kincaid et 
al., 2012). Moreover, deletion of the thymo-proteasome subunit β5t provides an 
additional model of proteasome dysfunction (Murata et al., 2007).  
Modulation of each of the mechanisms discussed above offers promising 
approaches to identify novel molecular pathways as targets the therapeutic treatment of 
devastating neurodegenerative diseases with no known cause (Fig. 1.3).   
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Figure. 1.3. Overview of the common pathogenic mechanisms of neurodegenerative 
diseases. Neuron death is the main cause of neurodegenerative diseases. Many 
mechanisms contribute to neuron death including activated astrocytes and 
microglia, oxidative stress, mitochondrial dysfunction, excitotoxicity, proteasome 











1.2. Nutraceutical compounds  
    After many clinical studies failed aimed to treat neurodegenerative disorders, 
with the long duration necessary to approve new drugs, and the increasing number of 
patients with neurodegenerative disorders, scientists have begun to investigate novel 
therapeutics for these diseases based on the underlying disease mechanisms. New 
pathways of exploration include patient lifestyle choices and a new examination of 
traditional and/or holistic therapies that may modulate the several of the common 
molecular pathways implicated in these disorders. In particular, oxidative stress and 
neuro-inflammation are two specific pathways which are implicated in several distinct 
diseases including PD, AD, and ALS. To block these pathways, scientists are beginning 
to study natural compounds (nutraceuticals) with antioxidant and anti-inflammatory 
properties.  
Since many nutraceuticals are not regulated by the FDA, they are not subject to 
the same regulatory hurdles as pharmaceutical drugs.  The term “nutraceutical” is created 
from two root words; nutrition and pharmaceutical. This term was originally coined by 
Stephen De Felice, the chairman of the Foundation for Innovation in Medicine (FIM), 
Cranford NJ in 1989 (Maddi et al., 2007; Brower 1998). According to Dr. Felice, the 
nutraceuticals cover any food or part of a food that possess healthy properties which can 
provide benefit against diseases. Nutraceuticals can be extracted as a product of food, and 
can be taken as a powder or supplement (Wildman, 2001; Bull, 2000). Many studies have 
investigated the medical benefits of a number of nutraceuticals, including those against 
cold and cough, sleeping disorders, cancer, depression, diabetes, and various 
neurodegenerative diseases (Pandey et al. 2010; Bhullar and Rupasinghe, 2013). In 
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addition to the bioactivities of nutraceutical compounds, many studies indicate that some 
of these compounds have the ability to cross the blood brain barrier and gain access to 
specific regions of the brain to provide beneficial effects (Choi et al., 2012). Thus, there 
is great interest in identifing new nutraceutical compounds with therapeutic effects for the 
treatment of neurodegenerative diseases. One class of these compounds that has gained 
significant attention is polyphenols.  
    1.2.1. Polyphenols.  
     Polyphenols are compounds produced as secondary metabolites, and are found 
in many plants, fruits, vegetables spices, oils, herbals, teas, and wine (Fig.1.4). These 
compounds possess significant antioxidant properties through their ability to either 
scavenge free radical species or increase the levels of antioxidants in organisms (Choi et 
al., 2012). The neuroprotective effect of polyphenols is due to their intrinsic antioxidant 
activity and their ability to enhance the capacity of endogenous cellular antioxidant 
molecules via activation of the Nrf2/ARE pathway. In turn, Nrf2 activates and modulates 
many antioxidants like γ-glutamylcysteine ligase, the rate-limiting enzyme for 
glutathione synthesis and an essential antioxidant compound (Dumont and Beal, 2011; 
Moskaug et al., 2005). In addition to the antioxidant properties of polyphenols, many in 
vitro studies have identified polyphenols as important modulators of other cellular 
process such as apoptosis, gene expression, and intracellular signaling (Duthie et al., 
2003). 
Anti-inflammatory activities of polyphenols have also been reported (González et 
al., 2011), therefore increasing insight into their ability to reduce the risk of many age-
related disorders, such as neurodegenerative disorders. Many studies demonstrate that the 
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anti-inflammatory effects of polyphenolic compounds lead to a reduction the production 
or the level of many cytokines and transcription factors which are related to the 
inflammation process.   For example, one in vivo study found that polyphenolic 
compounds can suppress multiple inflammatory biomarkers (Parelman et al., 2012). 
Moreover, diets containing fruits that are rich in polyphenols have been shown to reduce 
the level of Interleukin 6 (IL-6), a major pro-inflammatory cytokine (Joseph et al., 2016). 
In addition, nitric oxide (NO), one of the inflammatory mediators, is reduced by several 
different polyphenolic compounds (Soliman and Mazzio, 1998).  
An additional inflammatory marker shown to be modulated by polyphenols is the 
nuclear transcription factor (NF-κB). Under normal conditions, this transcription factor is 
found in the cytoplasm, but once activated by free radicals or inflammation, it 
translocates to nuclei and induces transcription of many genes involved in cellular 
process such as inflammation (Butcher and Denkers 2002).  Different polyphenolic 
compounds have been shown to significantly inhibit the activity of NF-κB transcription 
factor. Several studies suggest that a diet comprised of a high intake of polyphenol-rich 
foods improves cognitive performance in elderly people and reduces risk of dementia 
(Nurk et al., 2010; Polidori et al., 2009; Hughes et al., 2010; Morris et al., 2006). It has 
been reported that elderly people who are at the highest risk for degenerative disorders, 
demonstrate decreases in important antioxidants, which leads to the accumulation of 
ROS, an underlying pathophysiologic mechanism that many contribute to the onset or 
progression of neurodegenerative diseases. Thus, polyphenolic rich diets are one 




Figure. 1. 4. Common polyphenols and their natural sources.  A. Chemical structure 
of chlorogenic acid and one of its major sources, green coffee beans. B. Chemical 
structure of rosmarinic acid and rosemary herb, one of its main sources. C. 








    Coffee is the second most consumed drink in the world (Bae et al., 2014). 
Coffee contains different chemicals including caffeine, carbohydrates, lipids, vitamins, 
minerals, alkaloids, and polyphenols (Spiller, 1984). Many studies have demonstrated 
that coffee intake may have pharmacological benefits for the treatment of several chronic 
diseases. For example, in a study examining the effect of coffee on type 2 diabetes, coffee 
intake significantly reduced the risk of type 2 diabetes in women (Van Dam et al., 2006).  
Moreover, coffee consumption was demonstrated to decrease the risk of liver disease by 
controlling the level of enzymes that are well known to elevate liver damage (Homan and 
Mobarhan 2006). Coffee consumption has also been shown to reduce the risk of different 
type of cancer (Cano-Marquina et al., 2013). Finally, coffee intake has been demonstrated 
to mitigate the development of neurodegenerative diseases. Indeed, two studies 
demonstrated that drinking coffee on a regular basis lowered the risk of developing either 
Parkinson’s disease or Alzheimer’s diseases (Trevitt et al., 2009; De Mendonca et al., 
2010).  
   One the major polyphenolic component in coffee is chlorogenic acid (Figure. 
1.5) (Sato et al., 2011; Upadhyay and Mohan Rao, 2013). Chlorogenic acid is formed by 
the esterification of cinnamic acids, such as caffeic acid and ferulic acid, with quinic acid 
(Fang et al., 2016). The benefits of chlorogenic acid are attributed to several biological 
effects, such as anti-inflammatory and antioxidants activities (Shi et al., 2016). The 
antioxidant activity of cholorgenic acid is related to its chemical structure, which contains 
a phenolic hydroxyl group known to scavenge both the hydroxyl radical and superoxide 
anion radical (Bohn et al., 2014; Gallus et al., 2002; Padol and Hunt, 2004; Phan et al., 
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2003). Chlorogenic acid can also increase the expression of nuclear Nrf2, which is a 
known transcriptional regulator of many pro-survival antioxidant genes (Shi et al., 2016). 
Furthermore, chlorogenic acid suppresses the NF-kB-dependent transcription of pro-
inflammatory signaling pathway components and reduces the expression of pro-
inflammatory genes, including cytokines, chemokines, and adhesion molecules (Shen et 
al., 2012). In addition, chlorogenic acid also has been reported to exhibit significant pro-
survival biological activities including anti-carcinogenic (Rakshit et al., 2010), anti-
obesity (Cho et al., 2010), anti-microbial (Lou et al., 2011), anti-tumor (Granado-Serrano 
et al., 2007), anti-lipidemic activity, and anti-diabetic effects (Ong et al., 2013). Recent 
research indicates that chlorogenic acid may also inhibit the activity of HIV-1 RNase 
(Naso et al., 2014). In an in vivo study, chlorogenic acid reduced infarct volume and 
rescued sensory motor function in a rat model of transient middle cerebral artery 
occlusion (Lee et al., 2012). Chlorogenic acid has been suggested to reduce the risk of 
many health issues like type 2 diabetes and cardiovascular disease (Ranheim and 
Halvorsen 2005; Salazar-Martinez et al., 2004). 
Many findings indicate a promising effect of chlorogenic acid on neuronal 
survival. For instance, chlorogenic acid directly protects neurons in vitro from 
cytotoxicity and death that are induced by glutamate, perhaps by controlling the entry of 
Ca 2+ influx (Mikami and Yamazawa 2015). New evidence has also supported the 
positive effects of chlorogenic acid on the progression of specific neurodegenerative 
disorders, such as AD.  In the Oboh et al. (2013) study, the authors demonstrated that 
chlorogenic acid inhibits acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), 
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the key enzymes associated with the development of AD.  Thus, chlorogenic acid is a 
nutraceutical with significant promise for neurodegenerative disease therapy.  
More recently, a growing interest examining the pharmaceutical effects of the 
cholorgenic acid-derivative, caffeic acid, is emerging. Caffeic acid is a polyphenol 
compound that is abundant in many agriculture products such as fruits, vegetables, teas, 
and coffee (Moridani et al., 2001; Scalbert et al., 2005). Caffeic acid has a wide variety of 
health benefits including anti-inflammatory, anti-cancer, anti-thrombosis, anti-
hypertensive, anti-fibrosis, anti-viral, anti-oxidative, and anti-tumor properties (Touaibia 
et al., 2011; Rehman and Sultana, 2011; Roos et al., 2011; Scapagnini et al., 2011). A 
study on human peripheral blood mononuclear cells showed that cells pretreated with 
caffeic acid, and subsequently exposed to H2O2, are protected from the apoptotic damage 
that is induced by this ROS-inducing compound.  The authors further demonstrated that 
the protection against ROS may have been afforded by the free radical scavenging 
properties of caffeic acid.  Moreover, this study demonstrated that caffeic acid inhibits 
lipid peroxidation and protects DNA from oxidative damage (Khanduja et al., 2006).  
Caffeic acid also has been shown to have promising effects in animal models of 
AD. In one study, Kim et al. (2015) found that administration of caffeic acid to mice 
injected with Aβ25-35 peptide protected against both Aβ toxicity and oxidative stress, 
which are two of the most common hallmarks of AD (Kim et al., 2015). In the methyl-4-
phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of PD, several inflammatory 
factors are induced including interleukin (IL)-1beta, IL-6, and tumor necrosis factor 
(TNF)-alpha. However, administration of caffeic acid to mice inhibited pro-inflammatory 
the effect of MPTP treatment (Tsai et al., 2011). Caffeic acid was also demonstrated to 
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prevent neurotoxicity induced by acrolein in vitro.  This insult has the ability to mimic 
many mechanisms that underlie neurodegenerative pathways, such as those activated in 
AD. Indeed, pretreating cells with caffeic acid decreased neurotoxicity, ROS, and also 
preserved the essential endogenous antioxidant, glutathione (Huang e al., 2013). Thus, 
similar to chlorogenic acid, caffeic acid is neuroprotective in multiple models of neuronal 
toxicity and neurodegeneration.  
          Ferulic acid is another polyphenol compound found in coffee that is also a 
chlorogenic acid derivative. Recently, scientists have focused their attention on the 
potential of ferulic acid to treat many disorders given its anti-oxidant activity and anti-
inflammatory activities. Ferulic acid modulates many anti-oxidant enzymes, such as 
superoxide dismutase (SOD), catalase (CAT), as well as the chaperone heat shock protein 
(Hsp)-70 (Mancuso and Santangelo, 2014). Ferulic acid also has the ability to scavenge 
free radicals, and it is a promising therapy for various diseases that depend on the 
downregulation of NF-kB and enhancing the expression of antioxidant enzymes, such as 
cancer, cardiovascular diseases, and diabetes, (Mancuso and Santangelo, 2014).  
The pharmacological activities of ferulic acid also suggest that it may be a novel 
therapy for neurodegenerative diseases, such as AD. In a transgenic mouse line fused 
with Aβ peptise, pretreatment with ferulic acid considerably reduced memory loss and 
decreased the level of neuro-inflammation, reactive gliosis, and interleukin 1 beta (IL-
1B) production (Yan et al., 2001). Further, a study by Cho et al. (2005) demonstrated that 
long-term administration of ferulic acid reduced astrocyte activation induced by h-
amyloid peptide (1–42) in vivo. Higher doses of ferulic acid led to greater reductions of 
the inflammation bio-markers in vivo (Jin et al., 2005), and ferulic acid was also shown to 
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attenuate the microglia activated by LPS in a rat model of chronic neuro-inflammation 
(Wenk et al., 2004). Moreover, in a similar manner, an in vitro study showed that ferulic 
acid reduces several biomarkers of inflammation that are induced by LPS (Sakai et al. 
1997).  
Quinic acid is another chlorogenic acid metabolite, yet unlike caffeic acid and 
ferulic acid, quinic acid does not possess a phenolic hydroxyl group. Interestingly, the 
phenolic hydroxyl group is the main structural basis for the antioxidant properties of 
these compounds (Pandey and Rizvi 2009). Thus, perhaps it is not surprising that there 
are not currently many studies examining the neuroprotective effects of quinic acid. 
Nonetheless, limited evidence has demonstrated that quinic acid reduces NF-KB 
activation and displays anti-viral effects in vitro (Akesson et al., 2005; Wang et al., 
2009).   
Further, several studies described the bioactivities of quinic acid derivatives: 5-O-
trans-o-coumaroylquinic acid methyl ester, chlorogenic acid methyl ester, 4, 5-dicaffeoyl 
quinic, and macranthoin G (Hur et al., 2001). 4,5-dicaffeoyl quinic acid, one of its 
derivatives showed a significant neuroprotective effect against Aβ- induced toxicity in 
vitro (Hur et al., 2001). (2)3, 5-dicaffeoyl-muco-quinic acid, another derivative has the 
ability to enhance neurite outgrowth of PC12 cells (Hur et al., 2001). Thus, despite 
evidence demonstrating that quinic acid may be able to modulate neuronal survival, 
studies do not suggest that quinic acid mediates neuronal survival through significant 
antioxidant and/or anti-inflammatory properties, as do other chlorogenic acid metabolites 







Figure. 1. 5. Chemical structure of chlorogenic acid and its three major metabolites. 
A. Chemical structure of chlorogenic acid. B. Chemical structure of caffeic acid. C. 









1.2.3. Rosemary.  
    Medical plants have been used as a major source of various pharmacological 
agents for many decades. Rosemary is a Mediterranean herb that is considered a 
traditional therapy for many health conditions such as rheumatic diseases (Bellumori et 
al., 2015). Many studies have shown numerous bioactivities of rosemary extract 
including antioxidant, free radical scavenging, anti-inflammatory, antimicrobial, 
antipyretic, and antidiabetic properties (Erkan et al., 2008; Basaga et al., 1997; Arranz et 
al., 2015; Laham et al., 2013; Al attar and Shawush, 2015; Bakirel et al., 2008). All of 
these activities may be related to its major polyphenol components, which are carnosic 
acid and rosmarininc acid (Ribeiro et al., 2016) (Fig. 1.6). Rosmarinic acid, one of the 
major rosemary polyphenol constituents, has been reported in several studies to possess 
several pharmaceutical properties like anti-inflammatory, anti-oxidant, antitumor, anti-
viral, and antimicrobial effects (Bulgakov et al. 2012; Wu and Wang, 2012).  
 The promising properties of rosmarinsic acid prompted scientists to 
investigate the effect of this compound on human health disorders including, AD 
(Vladimir-Knezevic et al., 2014), cardiovascular disease (Karthik et al. 2011), and 
allergic inflammation (Sanbongi et al. 2004). Rosemary extract produced a dramatic 
inhibition of astrogliosis in a rat model of repetitive mild traumatic brain injury by 
decreasing the levels of the neuroinflammatory biomarkers, IL-1β, IL-6, and TNF-α 
(Song et al., 2016). The protective effects of rosmarinic acid have also been investigated 
in a mouse model of ALS. Administration of rosmarinic acid to ALS mice expressing a 
mutant SOD1 transgene, increased the life span, improved spinal cord morphology, 
prevented body weight loss, and increased motor performance (Shimojo et al., 2010). 
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Rosmarinic acid has also been demonstrated to protect skin cells from the exposure of 
solar ultra-violet radiation based on its antioxidant and anti-inflammatory activities (Kim 
et al., 2015). The anti-tumor effect of rosmarininc acid established in the Kim et al. 
(2015) study was based on the compound enhancing TNF-α-induced-apoptosis in human 
leukemia U937 cells. The antioxidant effects of rosmarinic acid were mediated via its 
free radical scavenging and this led to its protection from oxidative stress (Perez-Fons et 
al., 2010). Suppression of ROS, intracellular glutathione depletion, and suppressing 
different inflammatory cytokines has been demonstrated by treating human cells with 
rosmarinic acid (Zdarilova et al., 2009). Altogether, increasing evidence suggests that 
rosmarininc acid suppresses many pathways that contribute to neurodegenerative 
diseases.  
Carnosic acid is another polyphenolic compound abundant in rosemary 
(Rosmarinus officinalis L.), and it has been proposed that the majority of the antioxidant 
activity of rosemary extract may be attributed to carnosic acid (Aruoma et al., 1992). The 
chemical structure of carnosic acid captured the attention of researchers due to its 
similarity to caffeic acid. Intriguingly, carnosic acid contains the same phenolic hydroxyl 
group that is proposed to contribute to oxygen radical scavenging activity (Nakamura et 
al., 2003).  Numerous health benefits have been observed with carnosic acid such as, anti-
oxidant, anti-inflammatory, anti-carcinogenic, and anti-obesity (Hadad and Levy, 2012; 
Yesil-Celiktas e al., 2010; Park and Sungb, 2015). Furthermore, carnosic acid enhances 
the expression of many detoxifying enzymes like glutathione S-transferase (GST) and 
NADH-quinone oxidoreductase 1 (NQO1) (Debersac et al., 2001). The stimulation of 
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these types of enzymes may contribute to the ability of carnosic acid to protect cells from 
ROS and RNS, for instance, in RAW264.7 macrophages (Xiang et al., 2012). 
Several studies suggest different intracellular mechanisms to explain the 
neuroprotective effects of carnosic acid, and many of these mechanisms implicate 
modulation of the Nrf2 pathway.  In this scenario, carnosic acid binds to Keap1, the 
suppressor of Nrf2, and the latter translocates from the cytoplasm to the nucleus to bind 
the ARE of various genes. Lastly, the induction of transcription of phase 2 enzymes is 
activated due to the previous binding (Satoh et al., 2008). The anti-viral properties of 
carnosic acid have also been demonstrated in a study by Shin et al., (2013), which 
demonstrated that human respiratory syncytial virus (hRSV) replication and infection is 
inhibited in vitro by treatment of human adenocarcinoma alveolar basal epithelial cell 
line A549 cells with carnosic acid. Further, in an in vivo study, carnosic acid showed an 
anti-inflammatory action by inhibiting the cytokines, cycloxygenase-2 (COX-2), IL-1β, 
and TNF-α, which are known to mediate responses to inflammation in different cells 
(Mengoni et al., 2011).   
The neuroprotective effects of carnosic acid have also been examined in different 
disease models, both in vitro and in vivo. In a PD study, the authors demonstrated that 
pretreatment of either SH-SY5Y neuroblastoma cells or a rat model of PD with carnosic 
acid, protected against 6-hydroxydopamine (6-OHDA)-induced toxicity. The protection 
observed was related to the anti-antioxidant activity of carnosic acid through its ability to 
increase protein expression of ɣ-glutamateyl-cysteine ligase catalytic subunit, ɣ-
glutamyl-cysteine ligase modifier subunit, superoxide dismutase, and glutathione 
reductase.  Further, the anti-apoptotic properties of carnosic acid were also observed, 
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such as blocking the reduction of Bcl-2/Bax ratio and inhibiting 6-OHDA-induced 
caspase-3 cleavage (Wu et al., 2015). In an in vitro model of AD-related toxicity, it was 
demonstrated that carnosic acid protects cells from Aβ-induced apoptosis (Meng et al., 
2015). Thus, many lines of evidence suggest that carnosic acid may be beneficial for the 
treatment of neurodegenerative diseases caused, in part, by the production of toxic ROS 



























Figure. 1. 6. Chemical structure of major compounds in rosemary. A. Chemical 













1.2.4. Pyrroloquinoline quinone  
Pyrroloquinoline quinone (PQQ) is a bioactive compound that is found naturally 
in various foods, but with particularly high concentrations in fermented soy beans, green 
tea, kiwi, green peppers, and papaya (Kumazawa et al., 1995) (Fig. 1.7). Recently, PQQ 
has received attention due to its multiple bioactivities including antioxidant, anti-
inflammatory, anti-diabetic and anti-cancer properties (Yang et al., 2014; Harris et al., 
2013; Akagawa et al., 2015; Min et al., 2014).   However, it is distinguished from the 
previous compounds discussed in this thesis by its ability to stimulate mitochondrial 
biogenesis (Stites et al., 2006).  PQQ also influences many essential physiological 
processes in the cell, which were demonstrated in in vivo nutritional studies where mice 
were given a diet lacking in PQQ. PQQ-deficient mice showed attenuated in growth, 
immune response, and reproductive performance (Akagawa et al., 2015).  Also, a PQQ-
deficient diet was shown to lead to reduced mitochondrial quantity, and deficiencies in 
both lipid and energy metabolism in rats (Bauerly et al., 2011). Human studies have also 
demonstrated that dietary PQQ is essential for maintaining endogenous antioxidant levels 
and diminishing pro-inflammatory mediators (Harris et al., 2013). Furthermore, PQQ 
showed a substantial neuroprotective effect in multiple in vivo and in vitro studies.   
Pretreatment with PQQ prior to exposure to various oxidative stressors, demonstrated a 
noteworthy neuroprotection in SH-SY5Y neurolastoma cells (Hara et al., 2007; Nunome 
et al., 2008).   A similar protective effect was observed in vivo in rats with dietary PQQ. 
Addition of PQQ to the diet markedly improved learning ability when compared 
to control rats (Ohwada et al., 2008).  
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The protection afforded by PQQ occurs primarily through modulation of the NF-
KB pathway, resulting in the suppresion of numerous inflammatory mediators like TNF-
α, iNOS, and IL-1β, that are enhanced in vivo and in vitro by LPS treatment (Yang et al., 
2014).  The mechanism underlying the neuroprotective effects of PQQ against glutamate-
induced cell death have also been investigated. PQQ protects neurons from excitotoxicity 
in a PI3K/Akt-dependent manner that leads to stimulation of Nrf2 and regulation of 
antioxidant genes (Zhang et al., 2012).  Another protection pathway activated by PQQ 
has been demonstrated by Yang et al. (2015), and involves control of the mitochondria 
pathway.  In their study, PQQ induced the expression of pro-survival Bcl-2, and also 
decreased the Bax-dependent release of mitochondrial cytochrome c, therefore inhibiting 
apoptosis. As we mentioned above, PQQ also stimulates mitochondrial biogenesis, which 
was demonstrated by Chowanadisai et al. (2010) to occur through phosphorylation of 
cAMP response element-binding protein (CREB), the regulator of peroxisome 
proliferator-activated receptor-ɣ coactivator-1α (PGC-1 α). The latter, in turn, induces 
mitochondrial biogenesis by activating nuclear respiratory factors. One important point is 
that PQQ showed a remarkable protective effect against diverse mitochondrial inhibitors 
(Chowanadisai et al., 2010). Thus, PQQ is a potential therapy for many diseases that are 
caused by mitochondrial deficiency, such as PD, which is often referred to as a 
mitochondrial disorder. In this context, Zhang et al. (2014) studied the signaling 
pathways that are involved in the protective effects of PQQ against a PD model in vitro, 
elucidating a role for PQQ protecting against rotenone- induced injury via modulation of 
the expression of Bcl-2 and Bax, and by activation of the pro-survival ERK1/2 pathway. 
In another in vitro model based on the aggregation and amyloid fibril formation pathway 
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implicated in AD and PD, PQQ decreased both mechanisms and reduced cytotoxicity 
(Kim et al., 2010). It has also been suggested that PQQ is a promising therapy for AD and 
dementia. It is thought that reducing the expression of nerve growth factor (NGF) may 
contribute to AD and PD through hindrance of cholinergic neuron survival. Pretreatment 
with PQQ induced the level of NGF in vivo and in vitro (Yamaguchi et al., 1993).  
The neuroprotective effects of PQQ have been further investigated in diverse 
models of neurological disorders. Significant improvement in the recovery from 
traumatic brain injury in rats was observed with treatment of PQQ (Zhang et al., 2012). In 
addition, β-amyloid aggregation is one of the pathological hallmarks of AD and is a cause 
of apoptosis. Interestingly, PQQ significantly protects human neuroblastoma SH-SY5Y 
cells from death induced by β 25-35 peptide through modulation of Bcl-2, Bax, and 
caspase-3 (Zhang et al., 2009). In another study, a dramatic reduction in infarct size from 
focal cerebral ischemia, and improved behavior, have been demonstrated in rats after 
pretreatment or co-treatment with PQQ (Zhang et al., 2006). This neuroprotective 
compound may also have relevance as a potential therapy for stroke as a significant 
reduction of infarct size was demonstrated following PQQ treatment in an in vivo model 
of cerebral hypoxia/ischemia (Jensen et al., 1994). In summary, PQQ protects from 
several death pathways in neurons through not only antioxidant and anti-inflammatory 
effects, but also through its capacity to modulate mitochondrial biogenesis, intrinsic 








              














1.3. Models to study neuronal cell death and neuroinflammation 
1.3.1. Cerebellar granule neurons (CGNs) 
Finding a good model to study the molecular and cellular mechanisms of 
neurodegenerative diseases was a major challenge for scientists for decades. Primary 
cultures of cerebellar granule neurons (CGNs) have been recognized to be a standard 
model to study various fields of development, function, and neurobiology in vitro. While 
numerous studies have utilized various cells to study the pathways of neuronal cell death, 
CGNs have been proposed as the most reliable in vitro model to study survival and 
apoptotic pathway implicated in neuroprotection and neurodegeneration. One of the 
remarkable characteristics of this primary cell culture system is that some of the 
conditions and pathways that control neuronal survival and apoptosis in vivo can also be 
stimulated in culture in CGNs (Contestabile 2002). This is a very important component of 
properly investigating the neuroprotective effects of drugs or natural compounds as it 
allows for the design of appropriate experiments and manipulations of the cell death 
pathways.  
         Multiple molecular pathways that are implicated in neurodegenerative diseases 
were originally investigated utilizing CGNs as a model to study apoptosis the capacity of 
small molecules to reverse these effects.  For example, ROS-induced cell death is one of 
the most common death pathways implicated in neurodegenerative diseases that was 
initially characterized in in vitro CGNs cultures (Behl et al., 2000). As expected, the 
apoptotic death induced by ROS in CGNs can been reversed by using antioxidants and 
free radical scavenging compounds (Contestabile, 2001). In addition to ROS-induced cell 
death, excessive glutamate exposure and proteasome inhibition have also been 
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characterized in CGNs (Dessi et al., 1994; Canu et al., 2000).  ER stress and nitrosative 
stress also induce neuronal death, and have also been tested in CGNs have been usedto 
understand more about the pathological pathways in degenerative diseases and to find 
some way to manipulate them pharmacologically (Kosuge et al., 2006; Lin et al., 2001). 
CGNs require depolarizing condition by culturing in specific extracellular concentration 
of potassium which is approximately 25 mM (Balazs et al., 1988). The reduction from 25 
mM K + to 5 mM K + leads to CGNs apoptosis (Balazs et al., 1988). This paradigm of 
potassium deprivation is a well-charaxterized method to initiate and study survival 
signaling and intrinsic apoptosis Thus, CGNs are a good in vitro model system to study 
multiple pathways of neuronal cell death in vito.  
1.3.2. BV2 cells 
Accumulating evidence has linked neuroinflammation to neurodegenerative 
disorders. This molecular pathway has been investigated in order to identify novel 
therapies for such degenerative disorders. Microglia are the principle immune cells of the 
CNS, and they play a pivotal role in neuroinflammation. During the pathological 
progression of a neurodegenerative disorder, inflammation occurs following microglial 
activation (Cunningham, 2013). Henn et al. (2009) suggested the mouse BV2 cell line is 
a suitable alternative model for primary microglia, in order to reduce the experimental 
preparation time and animal use. Indeed, the similarity of inducing inflammation 
mediators in both primary microglial and BV2 cells has been demonstrated previously 
(Henn et al. 2009). BV2 cells have also been utilized in pharmacological studies. For 
example, LPS is a recognition factor known to activate both microglia and BV2 cell lines 
to induce neuroinflammmation (Fig. 1.8) (Onasanwo et al., 2016). To enhance 
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understanding of this death pathway, stimulation of BV2 microglia cells with LPS was 
investigated to study the anti-inflammatory effect of different compounds (Onasanwo et 
al., 2016). Thus, BV2 cells are an appropriate in vitro model to study neuroinflmmation 
and will be useful to identify novel compounds that are capable of inhibiting this 

























Figure. 1.8. BV2 mouse microglial cell line a standard model to study inflammation. 


















CHAPTER TWO: NEUROPROTECTION COMPARISON OF CHLOROGENIC 
ACID AND ITS METABOLITES AGAINST MECHANISTICALLY DISTINCT 
CELL DEATH-INDUCING AGENTS IN CULTURED CEREBELLAR 
GRANULE NEURONS AND BV2 CELL LINE. 
2.1. Abstract 
Although the number of patients diagnosed with neurodegenerative disorders like 
Alzheimer’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease is increasing, 
there are currently no effective treatments that significantly limit the neuronal cell death 
underlying these diseases. Chlorogenic acid (CGA), a polyphenolic compound found in 
high concentration in coffee, is known to possess antioxidant and free radical scavenging 
activity. In this study, we investigated the neuroprotective effects of CGA and its major 
metabolites in primary cultures of rat cerebellar granule neurons and BV2 the mouse 
microglia cell line. We show that CGA and caffeic acid displayed a dramatic protective 
effect against the nitric oxide donor, sodium nitroprusside. In marked contrast, ferulic 
acid and quinic acid had no protective effect against this nitrosative stress. While CGA 
and quinic acid had no protective effect against glutamate-induced cell death, caffeic acid 
and ferulic acid significantly protected neurons from excitotoxicity. Finally, caffeic acid 
was the only compound that displayed significant protective activity against hydrogen 
peroxide, proteasome inhibition, caspase-dependent intrinsic apoptosis, and endoplasmic 
reticulum stress in CGNs, and it protected BV2 cell from the inflammation induced by 
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LPS. These results indicate that caffeic acid displays a much broader profile of 
neuroprotection against a diverse range of stressors than its parent polyphenol, CGA, or 
the other major metabolites, ferulic acid and quinic acid. We conclude that caffeic acid is 
a promising candidate for testing in pre-clinical models of neurodegeneration. 
 
2.2. Introduction 
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, 
Huntington’s disease, and amyotrophic lateral sclerosis, are defined by the progression of 
nervous system dysfunction attributed to multiple factors including but not limited to, 
misfolding of proteins, mitochondrial dysfunction, excitotoxicity, and oxidative stress.  
Therapeutic strategies that focus on these underlying factors are promising approaches 
for the treatment of neurodegenerative diseases. Oxidative stress has been proposed as a 
common pathological mechanism of essentially all major neurodegenerative diseases, and 
typically results from excessive production of reactive oxygen species (ROS) consequent 
to mitochondrial injury or dysfunction (Carrì et al, 2015; Moon and Paek, 2015; 
Simoncini et al., 2015). 
 As a means of protecting against oxidative stress, cells are equipped with 
free radical scavenging defenses that prevent accumulation of ROS. In addition to 
enzymes that detoxify free radicals (e.g., superoxide dismutase and catalase), antioxidants 
are chemical substances that either directly scavenge ROS or indirectly induce the 
expression or activity of free radical scavenging systems that protect cells from oxidative 
stress. Based on their neuroprotective effects, antioxidants have been suggested as a 
viable approach to slow or halt the progression of neuronal cell loss in various 
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neurodegenerative diseases. However, clinical trials with many common antioxidants 
(e.g., vitamin E or vitamin C) have met with limited success, indicating that utilization of 
additional antioxidants with diverse mechanisms of action, or targeted intracellular 
delivery of these compounds (e.g., mitochondrial-targeted antioxidants), may be 
necessary to reveal their full therapeutic potential (Polidori and Nelles 2014; Jin et al. 
2014). Therefore, dietary intake of natural antioxidants that can directly scavenge free 
radicals, as well as induce endogenous antioxidant defenses, may be one useful approach 
to treat neurodegenerative diseases.  
 Polyphenols are an abundant class of micronutrients found in many plants 
and are typically regarded as safe when taken as dietary supplements (e.g., 
epigallocatechin 3-gallate (EGCG) and resveratrol). They have the impressive ability to 
scavenge ROS and reactive nitrogen species (e.g., nitric oxide). In addition, polyphenols 
have been shown to modulate apoptosis, inflammation, ion channels, signal transduction, 
and neurotransmitter release – all processes which are implicated in a number of 
neurodegenerative diseases (Bhullar and Rupasinghe, 2013). Therapies that implement 
dietary supplementation with these compounds have demonstrated their neuroprotective 
potential (Bhullar and Rupasinghe, 2013; Bigford and Del Rossi, 2014; Daglia et al., 
2014; Virmani et al., 2013). Although polyphenols directly scavenge ROS and nitric 
oxide, many studies have suggested that the antioxidant capacity of polyphenols is also 
dependent on their indirect activation of pathways like nuclear factor E2-related factor 2 
(Nrf2)/heme oxygenase-1 (Bhullar and Rupasinghe, 2013). Others have shown that 
polyphenols inhibit many pathways that cause neuronal cell death through 
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neuroinflammation, such as the nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB) and pro-inflammatory molecules like tumor necrosis factor alpha (TNF-α), 
interferon gamma (IFN-γ), and interleukin (IL)-1𝛽, IL-6, IL-17A, IL-22. (Spencer et al., 
2012). Polyphenols can also upregulate free radical detoxifying enzymes, including 
catalase, superoxide dismutase, and glutathione peroxidase (Bhullar and Rupasinghe, 
2013). Finally, polyphenols have been shown to modulate the expression of pro-survival 
and pro-apoptotic pathway components, such as Bcl-2 and Bax (Kelsey et al., 2010).   
Coffee, the second most consumed drink in the world, has been shown to have 
protective effects from diverse inflammatory diseases associated with oxidative stress 
(Andersen et al., 2006).  Coffee consists of many antioxidant compounds including its 
main element caffeine, polyphenols like CGA, and volatile aromatic compounds 
(Gonthier et al., 2003; Ludwig et al., 2014). Several studies have shown that oxidative 
stress biomarkers are inversely correlated with the consumption of coffee (Hori et al., 
2014; Kempf et al., 2010; Yoshida et al., 2008). Furthermore, coffee consumption 
enhances antioxidant capacity in vivo (Corrêa et al., 2012). In the context of 
neurodegeneration, several studies have documented that coffee intake is associated with 
a reduced risk of developing Parkinson’s disease (Ross et al., 2000; Sääksjärvi et al., 
2008; Costa et al., 2010).   
 Chlorogenic acid is a major polyphenolic component in many plants and is 
abundant in coffee - particularly in green coffee beans that contain from 5% to 12% CGA 
by weight (Farah and Donangelo 2006; Farah et al., 2008).  It is an ester of trans-
cinnamic acids (including caffeic acid, ferulic acid, p-coumaric acid) and quinic acid 
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(Clifford, 1999). Chlorogenic acid has diverse health benefits such as cardioprotective 
effects, lipid peroxidation inhibitory activity, anti-tumor effects, and antioxidant activity 
(Namba and Matsuse 2002; Wan et al., 2013).  
Caffeic acid is a derivative of CGA that also has antioxidant properties, a function 
dependent on its chemical structure (Rice-Evans et al., 1996). The neuroprotective effects 
of CGA and caffeic acid have been revealed through in vitro studies using rat brain, 
where both polyphenolic compounds have been shown to inhibit acetylcholinesterase 
activity and lipid peroxidation induced by various pro-oxidants, suggesting a possible 
beneficial effect for Alzheimer’s disease (Oboh et al., 2013). Caffeic acid has also been 
shown to reduce intracellular ROS produced by H2O2 and protects neuronal cells in vitro 
from this oxidative insult (Jeong et al., 2011).  
      Ferulic acid, a component of green coffee beans and another metabolite of 
CGA, has also been found to be an effective free radical scavenger. This antioxidant 
action is related to its phenolic hydroxyl group that donates electrons in order to render 
free radicals inert (Srinivasan et al., 2007). In addition to its intrinsic free radical 
scavenging activity, in vivo studies have established that administration of ferulic acid 
inhibits astrocyte activation induced by beta-amyloid peptide in mice (Cho et al., 2005).  
The neuroprotective effects of quinic acid, another metabolite of CGA, have been 
investigated through in vitro studies. Although not typically regarded as an antioxidant, 
various chemical derivatives of quinic acid have been shown to inhibit the toxicity 
induced by beta-amyloid peptide in PC12 cells (Hur et al., 2001). 
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In order to investigate the neuroprotective effects of CGA and some of its 
metabolites against a number of diverse mechanisms that contribute to neurodegenerative 
diseases, we pre-incubated cerebellar granule neurons (CGNs) with CGA, caffeic acid, 
ferulic acid, or quinic acid (Fig. 2.1), and then exposed them to different stressors that 
result in neuronal cell death.  Cell viability was measured by MTT assay, 
immunocytochemistry was used to visualize the microtubule network, Hoechst stain was 
used to visualize nuclear morphology, and nitrite level was assessed by the Griess assay. 
The results demonstrate that CGA, caffeic acid, and ferulic acid each show some 
neuroprotective effects; however, caffeic acid displays a much broader neuroprotective 
profile against a diverse range of neurotoxic stressors than CGA or ferulic acid. Based on 
its broad neuroprotective profile, caffeic acid is a viable therapeutic candidate for testing 



























2.3. Materials and methods  
2.3.1. Materials.   
Hoechst dye, monoclonal antibody to β-tubulin, paraformalde-hyde, glutamic 
acid, and glycine were obtained from Sigma Aldrich (St. Louis, MO). Fluorescein 
isothiocyanate (FITC)-conjugated secondary antibody for immunofluorescence was from 
Jackson Immunoresearch Laboratories (West Grove, PA), 3-(4,5-dimethythiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT) reagent was obtained from Life Technologies 
(Grand Island, NY) and made up in 1X phosphate buffered saline (PBS, pH 7.4). 
Brefeldin A was obtained from Cell Signaling (Danvers, MA). PS-341 was purchased 
from Bio Vision (Mountain View, CA). Sodium nitroprusside (SNP) was obtained from 
Calbiochem (San Diego, CA).  Chlorogenic acid, caffeic acid, ferulic acid, and quinic 
acid were obtained from Sigma Aldrich (St. Louis, MO).   Caffeic acid was solubilized as 
stock solutions in DMSO and other compounds were made in sterile water.  Griess 
reagent assay was obtained from Thermo Scientific (Waltham, MA). Lipopolysaccharide 
obtained from Sigma Aldrich (St. Louis, MO). Stock solution of glutamate/glycine was 
made in sterile water. Brefeldin A and PS-341 were solubilized as stock solutions in 
DMSO.  
2.3.2. Cell culture.  
2.3.2.1. Cerebellar granule neurons (CGNs) 
Cerebellar granule neurons (CGNs) were isolated from 7-day-old Sprague-
Dawley rat pups (15-19g) of both sexes as described previously (Linseman et al., 2001). 
Briefly, neurons were plated on poly-L-lysine-coated culture plates at a density of 
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2.0x106 cells/ml in Basal Modified Eagle’s medium (BME) containing 10% fetal bovine 
serum, 25 mM KCl, 2 mM L-glutamine, penicillin (100units/ml)-streptomycin 
(100µg/ml) (Life Technologies, Inc., Gaithersburg, MD). Cytosine arabinoside (final 
concentration of 10µM) was added after 24h to limit the growth of non-neuronal cells. 
With this protocol, the purity of granule neurons was ~95-99%. After 6 or 7 days in 
culture, CGNs were rinsed two times in serum-free culture medium containing 25mM 
potassium (25K-Serum) and maintained in the same medium for pre-incubation with 
either chlorogenic acid (10µM), caffeic acid (50µM), ferulic acid (50µM), or quinic acid 
(10µM), individually for 24h. Apoptosis was induced either by removal of depolarizing 
extracellular potassium (5mM KCl; 5K apoptotic condition), or by the direct addition of 
the following stressors: (1) the nitric oxide donor, sodium nitroprusside (SNP; 50µM), (2) 
100µM glutamate and 10µM glycine (Glu/Gly) to induce excitotoxicity, (3) hydrogen 
peroxide (H2O2; 50µM), (4) the proteasome inhibitor PS-341 (100 µM), or (5) the 
endoplasmic reticulum (ER)-Golgi transport inhibitor, Brefeldin A (15 µM). Pre-treated 
cells were treated overnight for approximately 16-18h with each stressor.  
2.3.2.2 BV2 cell line 
BV-2 cells were seeded on uncoated culture plates and maintained in DMEM 
supplemented with 10% fetal bovine serum, and penicillin (100units/ml)-streptomycin 
(100µg/ml) at 37° C in 5 % CO2. Next day we removed 1 ml of the medium from each 
well and pretreat cells with the same concentration from the four compounds that we used 
with CGNs for 24h.  Then we added LPS (1μg/ml) for an additional 17 h. After that we 
measured nitrite production by the Griess assay. 
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2.3.3. MTT assay.  
After overnight incubation with the appropriate stressor, 100µl of MTT reagent 
was added to each well followed by incubation at 37°C for an additional 4h. Two ml of 
DMSO was added to each well to dissolve formazan crystals and the medium containing 
the dissolved crystals was read immediately in a microplate reader (BIO-RAD microplate 
reader-550) at 570 nm. A blank containing 25K-Ser medium, MTT reagent, and DMSO 
was prepared in parallel, and incubated without cells.  The data were plotted as the 
percentage of cell viability relative to the control mean absorbance for each independent 
experiment. A minimum of n=4 experiments with duplicate wells for each treatment 
group were performed for each stressor. 
 
2.3.4. Immunocytochemistry and fluorescence imaging. 
CGNs were washed once in 1X PBS and then fixed with 4% paraformaldehyde 
for 45min at room temperature. Cells were then blocked and made permeable at room 
temperature for 1h using a solution of 5% BSA and 0.2% Triton X-100 in 1X PBS. Then 
they were incubated with a primary antibody to β-tubulin in 2% BSA and 0.2% Triton X-
100 in 1X PBS, overnight at 4°C. The next day, cells were washed 5 times with 1X PBS 
and then incubated for 1h at room temperature with FITC-conjugated secondary antibody 
diluted 1:250 in 2% BSA and 0.2% Triton X-100 in1X-PBS. To stain the nuclei, Hoechst 
staining (1:500) was added to the secondary antibody solution. The following day, cells 
were washed 5 times with 1 X PBS, and anti-quench solution prepared from 1X PBS and 
1-5 mg of p-phenylenediamine was added to the cells before imaging. Images were 
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captured using a 40X objective on a Zeiss Axiovert-200M inverted fluorescence 
microscope. 
2.3.5. Nitrite Assay 
After pretreated cells with the four compounds individually and add LPS, nitrite 
level was assessed by the Griess assay.  Sodium nitrite was used as standard to determine 
nitrite concentration, and absorbance was measured at 550nm. 
 
2.3.6. Statistical Analysis.  
Experiments were performed using duplicate or triplicate wells for each treatment 
condition. Graphic data represent the means±SEM for the number (n) of independent 
experiments performed. Statistical analysis was performed using either one-way analysis 
of variance (ANOVA) and a post hoc Tukey’s test or unpaired t test. Differences between 
treatment groups were considered statistically significantly different at a value of p<0.05. 
 
2.4. Results  
2.4.1. CGA and caffeic acid protect CGNs from nitrosative stress induced by the nitric 
oxide donor, sodium nitroprusside (SNP). 
CGNs were pre-incubated with CGA (10µM), caffeic acid (50µM), ferulic acid 
(50µM), or quinic acid (10µM) for 24h, and then treated in the presence or absence of 
SNP (50µM) for an additional 16-18h. To assess neuronal injury induced by SNP in 
CGNs, we first examined the integrity of the microtubule network and nuclear 
morphology. Compared to control cells, SNP caused a dramatic disassembly of the 
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microtubule network in CGNs as shown by immunostaining for β-tubulin (Fig. 2.2A). 
CGA and caffeic acid each substantially protected the microtubule cytoskeleton from 
damage induced by SNP. Nuclei were considered as apoptotic if fragmented or 
condensed as assessed by Hoechst staining. De-colorized (black & white) Hoechst 
staining images are shown in Fig. 2.2A and enlarged (2.5X) in Fig 2B to clearly show 
differences in nuclear size and morphology. Control cells displayed large intact nuclei. In 
contrast, SNP- treated CGNs showed very small and condensed nuclei (Fig 2.2B). 
However, nuclear condensation was decreased markedly by pre-incubation with either 
CGA or caffeic acid. Neither ferulic acid nor quinic acid had any effect on SNP-induced 
nuclear condensation or microtubule disassembly. In agreement with these morphological 
findings, quantitative measurement of cell viability by MTT assay confirmed that only 
CGA and caffeic acid significantly protected CGNs from nitrosative stress induced by 
SNP.  The data from four independent experiments are shown in Fig. 2.2C as the 
(means±SEM) percentage of viable CGNs relative to controls.  
   It should be noted that similar results were obtained when CGA and each of its 
metabolites were used at equivalent (50μM) concentrations for pre-treatment of CGNs. 
Because CGA and quinic acid each displayed a small amount of basal cytotoxicity at 
50μM in CGNs, for all subsequent experiments we utilized these two compounds at a 
concentration of 10μM. Regardless, for each stressor used, similar results were obtained 
to those shown when CGA and its metabolites were each used at equivalent (50μM) 





Figure 2.2.  Chlorogenic acid and caffeic acid protect CGNs from nitrosative stress. 
(A) CGNs were pre-incubated for 24h in serum-free culture medium containing 
25mM KCl  (Control; Con ) alone or with chlorogenic acid (CGA; 10μM), caffeic 
acid (CA; 50μM),  ferulic acid (FA; 50μM), or quinic acid (QA; 10μM). Cells were 
then incubated for an additional 16-18h with the nitric oxide donor, sodium 
nitroprusside (SNP; 50μM). Following incubation, CGNs were fixed and stained for 
β-tubulin (FITC; green) and nuclei were visualized with Hoechst staining (blue). De-
colorized (black & white) panels are shown to emphasize nuclear morphology. (B) 
The areas demarcated by the boxes in (A) were magnified 2.5X to show differences 
in nuclear size. (C) Quantification of cell viability following SNP exposure using an 
MTT assay. Results are expressed as a % of Con viability (set to 100%) and are 
shown as mean±SEM (n= 4 experiments performed in duplicate). ### p<0.001 vs. 
Con; ***p<0. 001, **p<0.01 vs. SNP; as assessed by one-way ANOVA with a post 




2.4.2. Caffeic acid and ferulic acid protect CGNs from excitotoxicity induced by 
glutamate/glycine. 
Next, we used glutamate/glycine co-treatment to trigger Ca2 +-dependent 
excitotoxicity in CGNs and investigate the protective effects of CGA and its metabolites.  
CGNs were pre-incubated with each of the four compounds as indicated above and then 
treated for a further 16-18h with glutamate/glycine (final concentrations; 100µM/10µM). 
The integrity of the microtubule network and nuclear morphology were assessed by 
immunocytochemistry for β-tubulin and Hoechst staining, respectively. Compared with 
untreated control cells, glutamate/glycine caused a marked disassembly of the 
microtubule network in CGNs (Fig. 2.3A). Furthermore, nuclei were fragmented or 
condensed following exposure to glutamate/glycine (Fig. 2.3A and enlarged 2.5X in Fig. 
2.3B). Pre-incubation with either caffeic acid or ferulic acid significantly reduced 
excitotoxic damage to the microtubule cytoskeleton and diminished the appearance of 
apoptotic nuclei (Figs. 2.3A, 2.3B). In contrast, neither CGA nor quinic acid protected 
CGNs from these morphological effects of excitotoxicity (data not shown). As an 
additional measure of neuroprotection, cell viability was measured by MTT assay. The 
data from four independent experiments are shown in Fig. 2.3C as the percentage of 
viable CGNs relative to controls (means±SEM). Glutamate/glycine caused a nearly 75% 
reduction in CGN viability that was unaffected by pre-incubation with CGA. However, 
caffeic acid and ferulic acid each provided significant protection from excitotoxicity-
induced cell death. Cells treated with quinic acid trended towards increased viability but 
the results did not reach statistical significance. These data show that only caffeic acid 
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Figure 2.3. Caffeic acid and ferulic acid protect CGNs from excitotoxicity induced 
by glutamate/glycine. (A) CGNs were pre-incubated for 24h with CGA or its 
metabolites as described in the legend to Figure 2A, and then exposed to 
glutamate/glycine (100μM/10μM; final concentrations) for 16-18h. Cells were 
stained for β-tubulin and nuclear morphology as described in Figure 2.2 (B) The 
areas demarcated by the boxes in (A) were magnified 2.5X to show differences in 
nuclear size. (C) Quantification of cell viability following glutamate/glycine (Glu/Gly 
or G/G) exposure using an MTT assay. Results are expressed as a % of Con 
viability (set to 100%) and are shown as mean±SEM (n= 4 experiments performed 
in duplicate). ###p<0.001 vs. Con; *p<0.05 vs. Glu/Gly; as assessed by one-way 






2.4.3 Caffeic acid uniquely protects CGNs from oxidative stress induced by hydrogen 
peroxide. 
Oxidative stress is a major factor underlying the neuronal cell death in diverse 
neurodegenerative disorders. Common ROS that cause oxidative stress include 
superoxide radical and hydrogen peroxide (H2O2). To examine the neuroprotective 
effects of CGA and its metabolites against oxidative stress, CGNs were pre-incubated 
with each of the four compounds as indicated above and then treated for a further 16-18h 
with H2O2 (50µM). In contrast to untreated control cells, CGNs exposed to H2O2 
displayed a notable alteration of the microtubule network, characterized primarily by a 
loss of smaller interconnecting processes (Fig. 2.4A). In addition, cells treated with H2O2 
demonstrated substantial nuclear condensation indicative of an apoptotic-like death (Figs. 
2.4A, 2.4B). Both of these effects were largely prevented by pre-incubation with caffeic 
acid. Consistent with these morphological findings, MTT assay results showed that only 
caffeic acid provided significant protection of CGNs (Fig. 2.4C). Incubation with H2O2 
decreased cell viability by approximately 80% while pre-incubation with caffeic acid 
prevented this reduction. These data demonstrate that among the compounds tested, 







Figure 2.4. Caffeic acid protects CGNs from the oxidative stress induced by 
hydrogen peroxide. (A) CGNs were pre-incubated for 24h with CGA or its 
metabolites as described in the legend to Figure 2.2A, and then exposed to H2O2 
(50μM) for an additional 16-18h. Cells were stained for β-tubulin and nuclear 
morphology as described in Figure 2.2. (B) The areas demarcated by the boxes in 
(A) were magnified 2.5X to show differences in nuclear size. (C) Quantification of 
cell viability following H2O2 exposure using an MTT assay. Results are expressed as 
a % of Con viability (set to 100%) and are shown as mean± SEM (n= 4 experiments 
performed in duplicate). ###p<0.001 vs. Con; **p<0.01 vs. H2O2; as assessed by one-




2.4.4. Caffeic acid exclusively protects CGNs from an inhibitor of ER-Golgi transport, 
proteasome inhibition, and caspase-dependent apoptosis. 
Additional mechanisms leading to neuronal cell death, besides those discussed 
above (nitrosative stress, excitotoxicity, and oxidative stress), include ER stress, 
proteasome inhibition, and caspase-dependent apoptosis, amongst others. In the next 
series of experiments, we evaluated the neuroprotective effects of CGA and its 
metabolites against Brefeldin A, an inhibitor of ER-golgi transport, a proteasome 
inhibitor (PS-341), and 5K-induced (caspase-dependent) CGN apoptosis. Brefeldin A 
suppresses transport between the ER and Golgi, eliciting inositol 1, 4, 5 triphosphate 
(IP3) receptor-dependent Ca2+ toxicity and caspase-9-mediated apoptosis in CGNs 
(Brewster et al., 2006). Proteasome inhibition induces CGN apoptosis by causing an 
accumulation of c-Jun and pro-apoptotic Bim (Butts et al., 2005). CGNs require a high 
extracellular potassium-regulated depolarization stimulus for survival in culture, and 
removal of this depolarization stimulus (by switching the culture medium from 25mM 
KCl to 5mM KCl; 5K apoptotic condition) induces CGN apoptosis via the intrinsic or 
mitochondrial apoptotic pathway (D’Mello et al., 1993; Watson et al., 1998; Linseman et 
al., 2002). When CGN survival was assessed by MTT assay, each of these stressors 
(Brefeldin A, PS-341, and 5K apoptotic medium) induced at least a 60% loss of cell 
viability (Figs. 2.5A-C). In cells pre-incubated with CGA and its metabolites, only those 
CGNs treated with caffeic acid displayed a significant enhancement of survival upon 
exposure to each of these diverse stressors. Thus, caffeic acid exclusively protects CGNs 
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from ER stress, proteasome inhibition, and caspase-dependent apoptosis, demonstrating 























                
                           
Figure 2.5. Caffeic acid protects CGNs from toxicity induced by Brefeldin A, the 
proteasome inhibitor PS-341, and the caspase-dependent apoptosis inducer, 5K 
medium. CGNs were pre-incubated for 24h with CGA or its metabolites as 
described in the legend to Figure 2.2A, and then exposed to Brefeldin A (Bref), PS-
341, or 5K apoptotic medium for an additional 16-18h. (A), (B), and (C) 
Quantification of cell viability (MTT assay) following incubation with Bref, PS-341, 
or 5K apoptotic medium, respectively. Results are expressed as a % of Con viability 
(set to 100%) and are shown as mean±SEM (n=4-6 experiments performed in 
duplicate). ###p<0.001, ##p<0.01 vs. Con; **p<0.01; *p<0.05 vs. Bref, PS-341, or 
5K; as assessed by one-way ANOVA with a post hoc Tukey’s test 
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2.4.5. Caffeic acid protects BV2 from inflammation induced by lipopolysaccharide (LPS) 
the inflammatory stimulator.  
 Inflammation is another mechanism implicated in neurodegenerative diseases 
that been investigated in this study. BV2 the mouse microglia cell line has been used as a 
model to study inflammation. Lipopolysaccharide (LPS) was added to enhance the 
production of pro-inflammatory mediators, including nitric oxide (NO). BV2 were pre-
incubated with CGA (10µM), caffeic acid (50µM), ferulic acid (50µM), or quinic acid 
(10µM) for 24h, and then treated in the presence or absence of LPS (1µG) for an 
additional 16-18h. On the next day, NO levels were masseur by Griess assay.  Caffeic 
acid decreased the level of NO induced by LPS. Hence, caffeic acid inhibits the 






























































2.6. Caffeic acid protects BV2 from inflammation induced by lipopolysaccharide 
(LPS) the inflammatory stimulator. Quantitative assessment of nitric oxide 
production by untreated BV2 microglia, and microglia stimulated by LPS alone or 
with chlorogenic acid (CGA; 10μM), caffeic acid (CA; 50μM), ferulic acid (FA; 
50μM), or quinic acid (QA; 10μM) pre-incubated for 24h. Data are represented as 
mean ± SEM (n= 3 experiments for nitric oxide assay). ###p<0.001 vs. Con; ***p<0. 











Coffee contains multiple antioxidant compounds including the polyphenol CGA. 
Coffee intake is associated with an enhanced antioxidant status and reduced risk of some 
neurodegenerative disorders, suggesting that coffee constituents, like CGA, are 
neuroprotective. In the current study, we compared the neuroprotective effects of CGA 
and its major metabolites against diverse stressors in cultured rat CGNs, an established 
model to study neuronal cell death (Maycotte et al., 2010), we also stimulated BV2 
microglia cells with LPS to investigate the anti-inflammatory effects of these compounds 
(Onasanwo et al., 2016). An investigation of seven different cell stressors demonstrated 
that CGA and ferulic acid each protected from one stressor, nitric oxide and glutamate, 
respectively. In contrast, caffeic acid showed a very broad range of neuroprotective 
activity against multiple stressors (Fig. 2.7). Although some previous studies have 
investigated the neuroprotective effects of CGA and its metabolites in vitro, this has not 
previously been explored in a systematic manner within a common cell system. Here, we 
systematically compared the neuroprotective effects of these compounds in primary 
CGNs and BV2 cell line challenged with diverse neurotoxic stressors. 
 Similar to our results showing that CGA and caffeic acid each protect 
CGNs against the nitric oxide donor SNP, these compounds have also been shown to 
reduce lipid peroxidation induced by SNP in rat brain in vitro (Oboh et al., 2013). The 
protective effects of CGA and caffeic acid against nitric oxide-induced neurotoxicity are 
likely due to direct free radical scavenging and appear to be dependent on the presence of 
a catechol moiety which is common to these two compounds (Fig. 6) (Kono et al., 1997). 
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 In the case of excitotoxicity induced by glutamate, caffeic acid and ferulic 
acid each significantly preserved the viability of CGNs. These results are consistent with 
a previous report indicating that caffeic acid protects primary cultures of rat cortical 
neurons from the excitotoxic effects of glutamate (Koo et al., 2006). Also in the same 
study, caffeic acid attenuated excessive calcium influx and reduced ROS generation 
caused by glutamate. In a similar manner, ferulic acid administration to pregnant mice 
protected the brains of the developing fetuses, possibly through the action of ferulic acid 
acting as an NMDA receptor antagonist (Yu et al., 2006).  
Similar to our results showing that caffeic acid protects CGNs from H2O2, pre-
incubation with caffeic acid also protected PC12 cells from this oxidative stress (Pavlica 
and Gebhardt, 2005). In addition, a study in rats showed that caffeic acid protects the 
brain against H2O2 in vivo (Pereira et al., 2006). The present study also revealed the 
unique protective effects of caffeic acid against CGN apoptosis induced by low 
potassium medium. Although we have not investigated the mechanism of this anti-
apoptotic effect, it seems plausible that caffeic acid may modulate pro-apoptotic or pro-
survival gene expression to suppress caspase activity in this neuronal system. For 
example, caffeic acid has been shown to decrease neurotoxicity induced by amyloid beta 
by modulating Akt signaling in HT22 mouse hippocampal cells (Huang et al., 2013). 
Caffeic acid also attenuated cell death of CGNs induced by the ER stressor Brefeldin A. 
On the other hand, one prior report showed that in SH-SY5Y neuroblastoma cells, caffeic 
acid did not inhibit cell death induced by tunicamycin, another ER stressor that acts 
through a distinct mechanism to that of Brefeldin A (Izuta et al., 2008). While Brefeldin 
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A acts by inhibiting transport between the ER and Golgi apparatus, tunicamycin inhibits 
protein glycosylation in the Golgi apparatus (Colanzi et al., 2013; Izuta et al., 2008). 
Therefore, the differences in the protective action of caffeic acid against Brefeldin A and 
tunicamycin likely reflects modulation of factors involved in ER-Golgi transport rather 
than protein glycosylation. Finally, caffeic acid also protected CGNs from cell death 
caused by the proteasome inhibitor PS-341. To our knowledge, there are no prior reports 
of caffeic acid protecting neurons from proteasome inhibition. One potential mechanism 
through which caffeic acid could mediate protection is by modulation of pro-apoptotic 
protein, Bim. Chronic exposure of CGNs to proteasome inhibition is shown enhance 
expression of Bim, inducing apoptosis (Butts et al., 2005). Caffeic acid is known to 
activate Akt, a known inhibitor of Bim signaling, which may promote cellular survival 
under conditions of proteasome inhibition (Huang et al., 2013). 
 Finally, caffeic acid protected BV-2 cell from the inflammation induced by LPS. 
Our data are in agreement with those that found caffeic acid decreased NO production 
induced by LPS in macrophage cells (Búfalo et al., 2013). That protection and inhibition 
of NO accumulation may be related to caffeic acid ability to block different pathway 
implicated in forming NO like NF-kB, and MAPK (Búfalo et al., 2013).  Pretreating BV-
2 with other compounds did not present any suppression of NO induced by LPS.   Our 
data were in contract with Shen et al. In their study chlorogenic acid decrease NO 
production that promote by LPS in microglia cells. That contrast may because we used 
lower concentrations of chlorogenic acid than in the Shen et al. study 
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In summary, based on our systematic comparison of the neuroprotective effects of 
CGA and its major metabolites in a single cell system, primary CGNs, we conclude that 
CGA protects only from nitrosative stress and ferulic acid protects only from glutamate 
excitotoxicity. In contrast, caffeic acid displays a broad neuroprotective profile against 
oxidative and nitrosative stress, excitotoxicity, intrinsic apoptosis, ER stress, proteasome 
inhibition and inflammation (Fig. 2.7). These findings suggest that caffeic acid is a 
promising candidate for pre-clinical testing in mouse models of neurodegeneration. In 
this context, caffeic acid phenethyl ester (CAPE) has been shown to limit dopaminergic 
neurodegeneration and dopamine loss in mouse and rat models of Parkinson’s disease, 
and CAPE also extends survival in a mouse model of amyotrophic lateral sclerosis 
(Fontanilla et al., 2011; Fontanilla et al., 2012; Barros et al., 2013). It is noteworthy that 
CAPE is rapidly hydrolyzed in vivo and its major metabolite is caffeic acid (Celli et al., 
2007). These facts may warrant a comparison of CAPE and caffeic acid in pre-clinical 
















Figure 2.7. The neuroprotective effects of chlorogenic acid and its metabolites in 
CGNs. The schematic shows the broad neuroprotective effect of caffeic acid against 
oxidative and nitrosative stress, glutamate excitotoxicity, proteasome inhibition, ER 
stress, caspase depended apoptosis, and inflammation. In contrast, CGA protects 
only from nitrosative stress and ferulic acid protects only from glutamate 
excitotoxicity. Quinic acid did not display any significant neuroprotective activity in 









CHAPTER THREE: THE NEUROPROTECTIVE EFFECTS OF ROSMARINIC 
AND CARNOSIC ACID ON PRIMARY CEREBELLAR GRANULE NEURONS 
3.1. Abstract  
Neurodegeneration in the brain is the main cause of many devastating diseases, 
such as amyotrophic lateral sclerosis (ALS), Alzheimer’s, and Parkinson’s diseases. All 
of these diseases are characterized by the progressive loss of neurons in specific regions 
of the brain and/or spinal cord through either apoptosis or necrosis. Oxidative and 
nitrosative stress, along with excitotoxicity and caspase activation, have been implicated 
as the major underlying causes of cell death. Nutraceutical products have recently been 
shown to have neuroprotective effects in a variety of in vitro and in vivo disease models. 
The two nutraceuticals under investigation in this study are rosmarinic and carnosic acid 
both of which are found at substantial concentrations in rosemary.  In this study, these 
two compounds’ability to attenuate damage to cultured cerebellar granule neurons 
(CGNs) was observed and recorded. Both rosmarinic and carnosic acid have been shown 
to mitigate these effects and reduce cell death when nitrosative stress is induced.  
Rosmarinic acid also notably protected neurons against glutamate-induced excitotoxicity. 
Furthermore, carnosic acid has the unique ability to protect CGNs from caspase-
dependent intrinsic apoptosis induced by removal of serum and depolarizing extracellular 
potassium in the cell culture medium (i.e., 5K apoptotic condition).  We additionally 
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revealed that carnosic acid protects CGNs from 5K conditions specifically by activating 
the phosphoinositide 3-kinase (PI3K) pro-survival pathway.  The aim of this study was to 
test the neuroprotective effects of these two compounds against these various different 
kinds of cell death in order to determine their usefulness in attenuating neurodegenerative 
diseases. 
3.2. Introduction 
Neurodegenerative diseases, or diseases of the brain with marked neuronal death 
and consequential loss of brain matter, are increasing in prevalence. Some of the most 
common neurodegenerative diseases include amyotrophic lateral sclerosis (ALS), 
Parkinson’s disease, and Alzheimer’s diseases. According to a study published by 
Environmental Health Perspectives in 2005, 50 million Americans a year are affected by 
a neurodegenerative disease (Brown et al., 2005). Because most neurodegenerative 
diseases are primarily sporadic in nature, an effective method of treatment would be to 
prevent or slow the dying of neurons in affected brain regions. Inflammation, misfolded 
proteins, mitochondrial dysfunction, oxidative and nitrosative stress and excitotoxicity 
are all thought to be major mechanisms in the pathology of various neurodegenerative 
diseases.  Thus, therapeutic agents that target multiple disease aspects may be the most 
viable treatment options. 
Since ancient times, plants have been used as natural treatments for acute and 
chronic disorders (Ghaffari et al., 2014). Over the last few decades, natural compounds 
which possess medical benefits (or nutraceuticals) have been proposed as promising 
treatment options for many diseases due to their intrinsic antioxidant abilities in 
scavenging reactive oxygen and reactive nitrogen species. The activities of many of these 
 
67 
compounds have been extensively investigated both within in vitro and in vivo models 
(Ghaffari et al., 2014). Manufactured or commercially synthesized drugs often have more 
activity than natural compounds. However, natural compounds have long term benefits 
and generally produce fewer side effects (Espin et al., 2007). Most of these nutraceuticals 
are abundant in potent phenolic antioxidant compounds, like phenolic acids, flavonoids, 
tannins, and lignans (Cai et al., 2004). 
Rosemary is a shrub found originally in different Mediterranean countries, and 
now it is found abundantly throughout the world. In addition to its common use as a spice 
in food, rosemary has been used in alternative and complementary medicine due to its 
antioxidant activity (Rašković at el., 2014).  In folk medicines, rosemary has been used as 
a therapy for different diseases including headaches, inflammatory diseases, and stomach 
problems (Rašković at el., 2014). Rosemary has significant intrinsic antioxidant activity 
which is due to its molecular constituents, such as carnosol, carnosic acid, ursolic acid, 
rosmarinic acid, and caffeic acid. 
 Rosmarinic acid (Figure 3.1A) is a polyphenol derivative of caffeic acid which 
has antioxidant capabilities (Bhatt et al., 2013). It is naturally present in a number of 
plants traditionally used in folk medicinal practices such as Orthosiphon diffusus, 
Orthosiphon staminus, Rosmarinus officinalis, Artemisia capillaris and Calendula 
officinalis (Scarpati and Oriente, 1958). It possesses many biological properties including 
antioxidant (Lee et al., 2008), anti-inflammatory (Erkan et al., 2008), anti-mutagenic 
(McKay and Blumberg, 2006), anti-angiogenic (Huang and Zheng, 2006), 
hepatoprotective, anti-neurodegenerative (Lee et al., 2008), and NF-κB down-regulating 
(Osakabe et al., 2004). Moreover, rosmarinic acid has been demonstrated to protect 
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dopaminergic neuronal cells by inhibiting nitric oxide (NO) production from activated 
glial cells (Lo et al., 2002; Park et al., 2008).  
Carnosic acid (Figure 3.1B) also possesses antioxidant activity that may be related 
to its ability to up-regulate endogenous free radical scavenging enzymes via activation of 
the Nrf2 transcriptional pathway (Satoh et al., 2008). In another study, carnosic acid 
showed a neuroprotective effect in vitro in human, induced pluripotent stem cells 
(hiPSC)-derived neurons and in vivo in a mouse model against cyanide-induced brain 
damage (Zhang et al., 2015). It also has antimicrobial properties (Birtic et al., 2015). In 
addition, both compounds have demonstrated neuroprotective effects in different 
neurodegenerative diseases. Rosmarinic acid has been shown to attenuate motor neuron 
death in a mouse model of familial ALS (Shimojo et al., 2010; Seo et al., 2015), and 
carnosic acid has been shown to have similar effects in a mouse model of Alzheimer’s 
disease (Azad et al., 2011).  
The purpose of the present study was to directly compare the neuroprotective 
effects of these two compounds against oxidative damage caused by nitrosative stress, 
excitotoxicity, and caspase activation in a single cell model of primary rat cerebellar 
granule neurons culture. Further, we have defined the signaling pathway that carnosic 
acid activates under 5K apoptosis conditions which rescues neurons from caspase 
activation. Apoptosis was measured morphologically by immunocytochemistry to 
visualize the microtubule network and Hoechst staining to visualize nuclear size and 
architecture.  To investigate the pro-survival pathway that carnosic acid activates when 
demonstrating its neuroprotective effects, we used several different inhibitors including 
wortmannin to inhibit PI3K, PD98059 to block MEK/ERK, and AKT inhibitor to 
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attenuate AKT pro-survival pathway signaling (Figure 3.2). Our data demonstrate that 
these compounds show overlapping and unique neuroprotective effects against different 
stressors that cause cell death. The unique neuroprotective mechanism of these two 
polyphenols has direct implications for designing future preclinical studies to evaluate the 



































































Figure 3.2. Overview of the pro-survival pathways that carnosic acid may activate 
when demonstrating its neuroprotective effects. Different inhibitors include 
wortmannin to inhibit PI3K, PD98059 to block MEK/ERK, and AKT inhibitor to 















 3.3. Materials and methods 
3.3.1. CGN Culture 
Cerebellar granule neurons (CGNs) were isolated as previously described 
(Linseman et al., 2001) from seven day-old Sprague Dawley rat pups. Cells were plated 
on poly-L-lysine coated six-well plates (35mm-diameter), with a density of 
approximately 2x106 cells/well in Basal Medium Eagle’s supplemented with 25mM 
potassium chloride, 2mM L-glutamate, 10% fetal bovine serum, and 2mM penicillin-
streptomycin (100U/mL/100µg/mL). 10µM cytosine arabinoside was added to the culture 
medium 24 hours after plating to inhibit the growth of non-neuronal cells. Cultures were 
~95% pure for granule neurons. The resulting CGNs were then incubated at 37˚C in 10% 
CO2 for six to seven days in culture prior to experimentation. All animal manipulations 
were performed in accordance with and under approval of the University of Denver 
Institutional Animal Care and Use Committee. 
 
 3.3.2. Reagents 
Sodium nitroprusside (SNP) and PD98059 were obtained from Calbiochem (San 
Diego, CA). Carnosic acid (4aR,10aS)-5, 6-Dihydroxy-1,1-dimethyl-7-propan-2-yl-
2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylic acid) and rosmarinic acid ((R)-O-
(3,4-Dihydroxycinnamoyl)-3-(3,4- dihydroxyphenyl) lactic acid, 3,4-Dihydroxycinnamic 
acid (R)-1-carboxy-2-(3,4-dihydroxyphenyl) ethyl ester) were obtained from AG 
Scientific (San Diego, CA). Glutamic acid was purchased from MP Biomedical (Santa 
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Ana, CA). Glycine, Hoechst, and wortmannin were obtained from Sigma Aldrich (St. 
Louis, MO). AKT inhibitor was purchased from Calbiochem (San Diego, CA).  
3.3.3 Treatment protocols.  
3.3.3.1. Protocol for Treatment with SNP/glutamate+glycine 
CGNs were co-treated with either carnosic or rosmarinic acid with the stressors 
SNP or glutamate-glycine (100μM/10μM), for 24 before fixation and Hoechst staining 
for quantification of cell death. For all experiments, an untreated control and an SNP or 
glutamate-glycine only control were used to compare cell death/protection. Prior to 
treatment, cell medium was removed and replaced with serum-free medium containing 25 
mM KCl to prevent any potential protective effects of the serum. 
3.3.3.2. Protocol for Treatment with 5K  
CGNs were co-treated with either carnosic or rosmarinic acid, and 5K medium. 
Prior to treatment, cell culture medium was aspirated, and the cells were washed once 
with 5K medium to remove any leftover serum.  5K medium contains of Basal Medium 
Eagle’s supplemented with 25mM potassium chloride, 2mM L-glutamate, and 2mM 
penicillin-streptomycin (100U/mL/100µg/mL).  After the first wash with 5K, the medium 
was removed and replaced with fresh 5K medium. Wells whose medium was never 
replaced, and wells with only 5K medium were used as controls. In the remaining 
experimental wells, the appropriate concentration of rosmarinic or carnosic acid was 
added. The cells were left in an incubator at 37˚C for 24 hours before fixation and 
staining with Hoechst for quantification of apoptosis.  
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3.3.3.3 Protocol for treatment with inhibitors 
CGNs were co-treated with varying concentrations of carnosic acid, and then 
either 5K medium, or 5K plus 10µM PD-98059, 100nM wortmannin, or 10μM AKT 
inhibitor. Cells whose medium was never replaced, and cells with only 5K were used as 
controls. Cells containing 5K plus the wortmannin, PD-98059, and AKT inhibitor 
without carnosic acid were also included as controls. Cells were treated and then left in 
an incubator for 24 hours before fixation, Hoechst staining, and quantification were 
carried out. 
3.3.4. Fixation and Hoechst Staining  
Following treatment, CGNs were washed once with phosphate buffered saline 
(PBS; pH=7.4) and fixed for one hour at room temperature in 4% paraformaldehyde. 
Cells were then washed again with PBS and stained with Hoechst (10µg/mL). After a 
minimum of one hour, the cells were imaged using a Zeiss Axiovert-200M epi-
fluorescence microscope. Five images were taken per well to assess apoptosis, with either 
duplicate or triplicate wells per experiment. Cells were counted and scored as either 
living or apoptotic based on nuclear morphology using images showing decolorized 
Hoechst fluorescence. CGNs having condensed or fragmented nuclei were counted as 
apoptotic. 
3.3.5. Data Analysis 
Each experiment was performed using either duplicate or triplicate wells for each 
treatment, with each experiment being performed at least three times. Data were 
represented as the means +/- SEM of the total number of experiments. Data was analyzed 
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using a one-way ANOVA with a post hoc Tukey’s test. A p-value of <0.05 was 




3.4.1 Carnosic acid and rosmarinic acids each protect CGNs from nitrosative stress 
SNP, a nitric oxide donor, has been shown to induce nitrosative stress, causing 
cell death through the formation of reactive nitrogen species (RNS) (Eu et al., 2000). 
Here, the efficacy of rosmarinic acid and carnosic acids against nitrosative stress was 
examined by assessing the extent to which these two compounds prevented cell death 
when cells were exposed to SNP. Cells death was determined by examining nuclear 
morphology, and the state of the neuronal processes under bright field imaging. It was 
found that SNP was very toxic to CGNs, as observed through their condensed and 
fragmented nuclei as compared to the nuclei of untreated control cells (Figure 3.2A). It is 
also evident through the bright field images that the neuronal processes are essentially 
destroyed by SNP. These effects were largely reduced by 50 µM rosmarinic acid, and to a 
slightly lesser but still significant extent by 10 µM carnosic acid (Figure 3.3A). 
Quantification of these results is shown in Figure 3.2B as the percentage of apoptotic 
cells counted using decolorized Hoechst fluorescence (Figure 3.3B) to assess nuclear 
morphology. By this method, it was found that rosmarinic acid significantly decreased 
cell death at doses of 50µM and 100 μM. Carnosic acid demonstrated a more potent 
protective effect, at dose of 10µM and 20µM. Moreover, at concentrations of over 20µM 
and 100µM of carnosic acid and rosmarinic acid, respectively, the compounds were 
somewhat toxic on their own to CGNs (data not shown).  
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Figure 3.3.  Rosmarinic acid and carnosic acid each protect CGNs from nitrosative 
stress. (A) CGNs were co-incubated for 24h in serum-free culture medium 
containing 25 mM KCl (Control; Con) alone, or with rosmarinic acid (ROS; 50 μM) 
or carnosic acid (CAR; 10μM) and sodium nitroprusside (SNP; 100 μM), or SNP 
alone.  Following incubation, CGNs were fixed and stained with Hoechst staining to 
visualize the nuclei. Decolorized (black & white) panels are shown to emphasize 
nuclear morphology (DAPI), and gray panels show the bright field images of the 
same fields. Scale bar indicates 10µm. (B) Quantitative assessment of cellular 
apoptosis for CGNs in untreated controls, 100µM SNP, and 100µM SNP plus 50 or 
100µM ROS, or 10 or 20 µM CAR. Cells were quantified by counting as either 
living or apoptotic based on nuclear morphology, and the percent of cells showing 
apoptotic nuclei (either condensed or fragmented morphology) was determined. 
Data are expressed as the mean +/- SEM, n=4. ### indicates p<0.001 compared to 
control, *** indicates p<0.001 compared to SNP alone as determined using one-way 
ANOVA with a post hoc Tukey’s test. 
 
77 
3.4.2. Rosmarinic acid protects uniquely CGNs against excitotoxicity. 
 Glutamate and its co-agonist glycine, when introduced to cells, are known 
to cause excitotoxicity through an influx of calcium. The molecules bind to ionotropic 
glutamate receptors, allowing extracellular calcium to enter and greatly depolarize the 
cell. This increase in intracellular calcium can activate calpains, form reactive oxygen 
species (ROS) and RNS, and more generally cause the neuron to fire more action 
potentials, causing further depolarization and increased frequency of the aforementioned 
issues with high concentrations of intracellular calcium (Arundine and Tymianski 2003). 
Rosmarinic acid notably protected CGNs against the insult of glutamate-glycine 
(100μM/10μM); however, carnosic acid appended to worse the effects of glutamate-
toxicity (Figure 3.3). To assess the extent to which CGNs were damaged by the insult 
with glutamate and glycine, the cells were imaged and quantified by looking at 
decolorized Hoechst images for nuclei stability and integrity (Figure 3.4A). The 
percentage of apoptotic cells was determined for each treatment and the quantitative 
results are shown in Figure 3.4B. Rosmarinic acid significantly protected CGNs from 
excitotoxicity at 20μM and 50μM concentrations. In contrast, carnosic acid at doses of 
10μM and 20μM enhanced the CGNs cell death in the presence of glutamate, though this 








Figure 3.4. Rosmarinic acid, but not carnosic acid, protects CGNs from 
excitotoxicity. (A) CGNs were co-incubated for 24h in serum-free culture medium 
containing 25 mM KCl (Control; Con) alone or with rosmarinic acid (ROS; 20 μM) 
or carnosic acid (CAR; 10μM) and glutamate/glycine (G/G; 100μM/10μM final 
concentrations), or G/G alone.  Following incubation, CGNs were fixed and stained 
with Hoechst staining to visualize the nuclei. Decolorized (black & white) panels are 
shown to emphasize nuclear morphology (DAPI), and the gray panels show the 
bright field images of the same fields. Scale bar indicates 10µm.  (B)  Quantitative 
assessment of cellular apoptosis for CGNs in untreated controls, G/G 
(100μM/10μM) alone, and G/G plus 20 or 50 µM ROS, or 10 or 20 µM CAR. Cells 
were quantified as either living or apoptotic based on nuclear morphology, and the 
percent of cells showing apoptotic nuclei (either condensed or fragmented 
morphology) was determined. Data are expressed as the mean +/- SEM, n=4. ### 
indicates p<0.001 compared to control, *indicates p<0.05 compared to G/G alone as 




3.4.3. Carnosic acid uniquely protects CGNs against caspase activation 
 5K is a non-depolarizing, low potassium medium that causes caspase 
activation in CGNs. Caspases cause what is known as programmed cell death when 
activated. When the cell undergoes stress, such as the low potassium conditions seen with 
this insult, pro-apoptotic proteins are ultimately activated. There are several pro-survival 
cell signaling pathways that can be inactivated by 5K medium to allow caspase activation 
and subsequent death of the cell. Stimulation of these pathways under 5K conditions can 
therefore lead to cell survival and neuronal protection. The specific pathways we tested in 
subsequent experiments were the pro-survival PI3K, MEK/ERK, and AKT pathways. 
Carnosic acid significantly protected CGNs against 5K-induced apoptosis, whereas 
rosmarinic did not (Figure 3.5). These results were again quantified from decolorized 
Hoechst images (Figure 3.5B), and the percentage of apoptotic cells was determined. 
Conversely to the results observed with glutamate, carnosic acid significantly protected 
against the 5K insult at 10μM and 20μM. Additionally, 5K treatment alone damaged 
processes to a lesser extent than either SNP or glutamate treatment (Figure 3.5A); 
however, treatment with carnosic acid did improve the overall integrity of neuronal 













Figure 3.5.   Carnosic acid, but not rosmarinic acid, protects CGNs from caspase 
activation. (A) CGNs were co-incubated for 24h in serum-free culture medium 
containing 25mM KCl (Control; Con). Treated cells had 25 mM KCl medium 
replaced with a non-depolarizing, low potassium medium (5K medium) either alone 
or with carnosic acid (CAR; 20 μM). Following incubation, CGNs were fixed and 
stained with Hoechst (blue) and β-tubulin antibody (green) staining to visualize the 
nuclei and tubulin respectively. Scale bar indicates 10µm. (B) Quantitative 
assessment of cellular apoptosis for CGNs in untreated controls, 5K, and 5K plus 20 
or 50 µM ROS, or 10 or 20 µM CAR. Cells were quantified as either living or 
apoptotic based on nuclear morphology, and the percent of cells showing apoptotic 
nuclei (either condensed or fragmented morphology) was determined. Data are 
expressed as the mean +/- SEM, n=4. ### indicates p<0.001 compared to control, 
*** indicates p<0.001 compared to 5K media alone as determined using one-way 








3.4.4. Carnosic acid protects CGNs from 5K-induced apoptosis through PI3K activation, 
but not AKT or MEK/ERK signaling.  
    Once it was determined that carnosic acid protected CGNs against 5K-induced 
and caspase activation, we attempted to determine if these protective effects were due to 
activation of specific pro-survival pathways that would inhibit caspase activation. First, 
the PI3K pathway was investigated using wortmannin, a known PI3K inhibitor (Wymann 
et al. 1996). It was determined that PI3K inhibition with wortmannin counteracted the 
protective effects of carnosic acid (Figure 3.6). Decolorized Hoechst images for this 
experiment are shown in Figure 6A, and were quantified to determine the percentage of 
apoptotic cells (Figure 3.6B). The results showed that cells containing 5K medium, 
carnosic acid, and wortmannin looked like the cells containing 5K medium alone. Thus 
wortmannin effectively reversed the protective effect of carnosic acid seen under 5K 
apoptosis conditions (Figure 3.6B). These findings demonstrated that the protective 
effects of carnosic acid against 5K-induced apoptosis are PI3K dependent. 
    The next pathway investigated was the AKT pro-survival pathway, one of the 
pathways activated downstream of PI3K. We blocked this pathway by using an AKT 
inhibitor. The protective effect of carnosic acid was sustained even in the presence of the 
AKT inhibitor. Decolorized Hoechst images for this experiment are shown in Figure 7A 
and were quantified to determine the percentage of apoptotic cells (Figure 3.7B). The 
results demonstrate that carnosic acid protects CGNs from 5K-induced apoptosis 




Figure 3.6. Carnosic acid protects CGNs from caspase activation through the PI3K 
pro-survival pathway. (A) CGNs were co-incubated for 24h in serum-free culture 
medium containing 25 mM KCl (Control; Con). Treated cells had 25K mM KCl 
medium replaced with a non-depolarizing, low potassium medium (5K medium) 
either alone, with carnosic acid (CAR; 20 μM), with wortmannin (Wort; 100 nM), 
or with Wort and CAR. Following incubation, CGNs were fixed and stained with 
Hoechst staining to visualize the nuclei. Decolorized (black & white) panels are 
shown to emphasize nuclear morphology (DAPI), and the gray panels show the 
bright field images of the same fields. Scale bar indicates 10µm. (B) Quantitative 
assessment of cellular apoptosis for CGNs in untreated controls, 5K, 5K plus Wort, 
5K plus 20 μM CAR, and 5K plus Wort and 20 μM CAR. Cells were quantified by 
counting as either living or apoptotic based on nuclear morphology, and the percent 
of cells showing apoptotic nuclei (either condensed or fragmented morphology) was 
determined. Data are expressed as the mean +/- SEM, n=4. ### indicates p<0.001 
compared to control, *** indicates p<0.001 compared to 5K media alone as 




     Finally, we investigated the MEK/ERK pathway by using PD98059, a known 
MEK/ERK inhibitor that works through binding to inactive MEK-1 and prevents 
subsequent downstream activation of pro-survival ERK signaling (Crews et al., 1992). 
Carnosic acid significantly protected CGNs from 5K-induced apoptosis even in the 
presence of PD98059 (Figure 3.8A, 3.8B). This suggests that carnosic acid prevents 
















Figure 3.7. Carnosic acid protects CGNs from caspase activation independently of 
the AKT pro-survival pathway. (A) CGNs were co-incubated for 24h in serum-free 
culture medium containing 25mM KCl (Control; Con). Treated cells had 25 mM 
KCl medium replaced with a non-depolarizing, low potassium medium (5K 
medium) either alone, with carnosic acid (CAR; 15 μM), with AKT inhibitor (AKT 
inh; 10 μM), or AKT inh and CAR. Following incubation, CGNs were fixed and 
stained with Hoechst (blue) and β-tubulin antibody (green) staining to visualize the 
nuclei and tubulin, respectively. Scale bar indicates 10µm.  (B) Quantitative 
assessment of cellular apoptosis for CGNs in untreated controls, 5K, 5K plus AKT 
inh, 5K plus 15 μM CAR, and 5K plus AKT inh and 15 μM CAR.  Cells were 
quantified by counting as either living or apoptotic based on nuclear morphology, 
and the percent of cells showing apoptotic nuclei (either condensed or fragmented 
morphology) was determined. Data are expressed as the mean +/- SEM, n=4. ### 
indicates p<0.001 compared to control, *** indicates p<0.001 compared to 5K media 








         
Figure 3.8. Carnosic acid protects CGNs from caspase activation independently of 
the MEK/ERK pro-survival pathway. (A) CGNs were co-incubated for 24h in 
serum-free culture medium containing 25mM KCl (Control; Con). Treated cells had 
25 mM KCl medium replaced with a non-depolarizing, low potassium medium (5K 
medium) either alone, with carnosic acid (CAR; 10 μM), with PD98059 (PD; 10 
μM), or PD and CAR. Following incubation, CGNs were fixed and stained with 
Hoechst staining to visualize the nuclei. Decolorized (black & white) panels are 
shown to emphasize nuclear morphology (DAPI), and the gray panels show the 
bright field images of the same fields. Scale bar indicates 10µm. (B) Quantitative 
assessment of cellular apoptosis for CGNs in untreated controls, 5K, 5K plus PD, 5K 
plus 10 μM CAR, and 5K plus PD and 10 μM CAR. Cells were quantified by 
counting as either living or apoptotic based on nuclear morphology, and the percent 
of cells showing apoptotic nuclei (either condensed or fragmented morphology) was 
determined. Data are expressed as the mean +/- SEM, n=4. ### indicates p<0.001 
compared to control, *** indicates p<0.001 compared to 5K media alone as 







Rosmarinic acid and carnosic acid have many bioactivities, including acting as 
antioxidants, that may make them viable therapeutic options to diminish the underlying 
pathophysiology of various neurodegeneration diseases. In the current study, we 
compared the neuroprotective effects of rosmarinic acid and carnosic acid against 
different stressors in cultured rat CGNs, a well-established in vitro model to examine 
neuronal cell death (Maycotte et al., 2010). Moreover, we studied diverse mechanisms 
that may underlie the protective effects of carnosic acid against intrinsic apoptosis.   
Our data show that both rosmarinic acid and carnosic acid protected neurons from 
an in vitro model of nitrosative stress induced by sodium nitroprusside (SNP). This 
compound is a nitric oxide (NO) donor which can form highly toxic reactive nitrogen 
species (RNS) such as peroxynitrite (Tsang and Chung 2009). When these toxic RNS 
form, they cause extensive cellular damage, often resulting in death (Tsang and Chung 
2009).  The neuroprotective effects of rosmarinic acid are potentially linked to its abilities 
to down regulate NF-ĸB and inhibit NO production from activated glial cells (Osakabe et 
al., 2004; Lo et al., 2002; Park et al., 2008).  However, rosmarinic acid may also directly 
scavenge RNS like NO. Moreover, both compounds share a common catechol moiety 
that acts as a hydrogen donor to free radicals and uses oxygen as an electron acceptor 
(Oliveira et al., 2011). Furthermore, rosmarinic acid has previously been shown to have 
both anti-inflammatory and antioxidant effects, and to attenuate motor neuron death in a 
familial mouse model of ALS (Petersen and Simmonds 2003; Shimojo et al., 2010). Our 
results are consistent with a previous study, in which rosmarinic acid inhibited NO 
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production in RAW2647 mouse macrophages (Huang et al., 2009). Carnosic acid has 
also been shown to effects of NO level that was induced by LPS in microglial cells 
(Yanagitai et al., 2012). Thus, both rosmarinic acid and carnosic acid appear to mitigate 
nitrosative stress via two mechanisms. First, these compounds blunt NO production from 
macrophages and microglia. Second, they can act as direct scavengers of RNS like NO.  
       To understand the capacity of these compounds to mitigate different death 
pathways that are involved in neurodegenerative diseases, we investigated their 
protective effects in other models of neuronal cell death. Excitotoxicity has been shown 
to play a role in these diseases, and therefore was tested with these agents to determine 
their neuroprotective effects (Meredith et al., 2009). To replicate excitotoxicity in vitro, 
CGNs were exposed to glutamate and glycine. When NMDA are receptors are activated 
by phosphate and open, these calcium channels are over stimulated. Neuronal nitric oxide 
synthase (nNOS) is subsequently activated and produces NO, and nitrosative and 
oxidative stress effects can be observed, in addition to calcium overload and calpain 
activation (Tsang and Chung 2009). We found that rosmarinic acid showed significant 
protection against this particular type of cell death. Carnosic acid conversely enhanced 
cell death caused by excitotoxicity. The opposite effects of these compounds on 
excitotoxic cell death are striking and are not readily explained. Additional studies are 
necessary to define the mechanisms underlying these results. Rosmarinic acid showed a 
significant and unique neuroprotective effect against excitotoxicity, which has been 




    Our study found that carnosic acid specifically worsened the effects of 
excitotoxicity in CGNs, while other studies have found it to antagonize intracellular 
calcium mobilization in leukocytes (Poeckel et al., 2008). Another study suggested that 
carnosic acid has anti-excitotoxic effects in vivo and in vitro neuronal models (e.g., HT22 
hippocampal cells) (Satoh et al., 2008). The conflicting finding between our study and 
these prior reports may be due to the different cell types utilized. Regardless of these 
effects, carnosic acid protected CGNs against 5K apoptosis conditions, whereas 
rosmarinic acid did not. This protocol subjects the cells to low potassium conditions, 
subsequently causing caspase activation independent of nitrosative or oxidative stress, 
resulting in programmed cell death (PCD) or intrinsic apoptosis.  
     To further characterize how carnosic acid protected against this specific type 
of cell death, different inhibitors were used to test the involvement of specific cell 
survival pathways. One of the pathways examined was the PI3K pro-survival pathway, 
which was inhibited by wortmannin. Wortmannin suppressed the protective effects of 
carnosic acid seen in 5K medium, suggesting that the neuroprotective effects of this 
compound are dependent upon activation of the PI3K signaling pathway. A previous 
study reported that pretreating IMR-32 cells with wortmannin decreases Nrf2 nuclear 
translocation (Lee et al., 2001). Based on this result, the authors proposed that Nrf2 is 
activated downstream of PI3K.  Satoh et al. have reported that carnosic acid activates 
Nrf2 in vivo and in vitro, and activates the transcriptional antioxidant response element 
(ARE) of phase-2 genes that modulate the cellular redox state (Satoh et al., 2008, Satoh et 
al., 2008b).  Thus, the dependence of carnosic acid in neuroprotection against 5K-
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apoptosis in CGNs on PI3K may involve subsequent activation of Nrf2. However, this 
result seems somewhat unlikely, since 5K-induced apoptosis in CGNs occurs largely 
independent of oxidative stress.  
We also examined the AKT pathway, another pro-survival signaling pathway that 
commonly act downstream of PI3K. To block this pathway, we added an AKT inhibitor 
to CGNs along with carnosic acid and 5K media. Carnosic acid protected against 5K-
induced apoptosis even in the presence of the AKT inhibitor, suggesting that the PI3K-
dependence of carnosic acid neuroprotection is not due to activing AKT.   
    The effects of MEK/ERK were then investigated using PD98059. This 
compound is a MEK/ERK inhibitor, another cell signaling pathway involved in cell 
survival.  MEK/ERK can be activated downstream of PI3K activation of Ras. However, 
carnosic acid protected against 5K medium even in the presences of PD98059. This result 
showed that carnosic acid protects from apoptosis independently of the MER/ERK pro-
survival pathway.  
 Since we have tested two pro-survival cell signaling pathways activated 
downstream of PI3K (AKT and MEK/ERK), and neither was implicated in the protective 
effect of carnosic acid, this indicate that, carnosic acid protects CGNs through another 
PI3K-dependent pathway (Nakaso et al., 2003). One of these other PI3K-dependent 
pathways could potentially be Nrf2 activation. Carnosic acid has been reported as an 
activator of Nrf2. So we considered that carnosic acid could protect against caspase 
activation by activation of PI3K, and subsequently Nrf2 activation.  However, as 
indicated above, this seems unlikely since CGN apoptosis induced by 5K does not have a 
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significant oxidative stress component. Another possibility is a PI3K-dependent 
activation of Ras GTPase and subsequent activation of P21-activated kinase (PAK) 
(Marinissen and Gutkind 2001). Indeed, Ras and PAK signaling has been shown to be an 
important pro-survival pathway for CGNs (Stankiewicz et al., 2015). Future studies will 
examine if carnosic acid activates Rac/Pak in CGNs.  
    Rosmarinic acid has demonstrated neuroprotective effects in numerous 
different studies, as well as it has been shown to protect against types of cell death not 
examined in this study. For instance, other studies have shown rosmarinic acid to protect 
against Aβ insults (commonly seen in Alzheimer’s disease) by mitigating similar types of 
cell death as were examined in this paper (Iuvone et al.  2006). Aβ toxicity can cause cell 
death through the generation of reactive oxygen species (ROS), lipid peroxidation, DNA 
fragmentation and caspase activation (Iuvone et al.  2006). Interestingly, we found that 
rosmarinic acid did not protect from caspase activation induced by 5K medium. The 
experiments completed in this study, as well as results from other studies, find rosmarinic 
acid to be an effective neuroprotective agent, though the method by which it attenuates 
certain types of cell death (e.g., Aβ-induced apoptosis) is still largely unknown. This is 
the next step that should be investigated. If the method by which this compound protects 
against cell death could be discovered, it could have vast implications for future 
neurodegenerative disease therapies.  
Carnosic acid has also been shown in multiple studies, through its electrophilic 
properties, to activate the transcription factor Nrf2 (Satoh et al. 2008; Takahashi et al. 
2009). Various NRF-2- specific enzymes, for example heme oxygenase-1 (HO-1), are 
 
91 
antioxidant molecules that provide efficient cell protection through regulating the 
intracellular redox state (Satoh et al. 2008). In this regard, the protective abilities seen by 
carnosic acid could be in part due to its electrophilic capabilities, combined with its 
antioxidant properties. This finding is interesting because it could have an impact on how 
neuroprotective compounds are regarded in the future. If electrophilic molecules also 
attenuate cell death as Satoh et al. 2008suggest, the research of neurodegenerative 
diseases could be expanded and perhaps even shifted. If electrophiles prove to be more 
effective at preventing cell death, there are potentially many more compounds that could 
demonstrate such effects. 
Rosmarinic and carnosic acid, when taken together, could have many important 
and beneficial uses. Both compounds showed a protective effect against the NO donor 
SNP. Rosmarinic acid uniquely protected CGNs from excitotoxicity, and carnosic acid 
uniquely protected CGNs from intrinsic apoptosis induced by 5K medium. Both have 
been shown to have impressive antioxidant and neuroprotective effects. These effects 
nicely complement each other, and add a potential future combination therapy for 





















CHAPTER FOUR: PQQ PROTECTS CGNS FROM OXIDATIVE STRESS  
4.1. Abstract 
Neurodegenerative disorders are devastating and fatal disorders of the nervous 
system that remain a critical focus of scientific research today. The underlying etiological 
features of neurodegenerative diseases consist of many mechanisms known to cause 
neuronal death, including oxidative stress, mitochondrial dysfunction, excitotoxicity, and 
nitrosative stress. Pyrroloquinoline quinone (PQQ) is a polyphenolic compound that is 
found in high concentrations in fermented soybeans, parsley, and green tea. Recently, 
PQQ has received significant of attention as a protective compound given its antioxidant 
and anti-inflammatory bioactivities. Moreover, PQQ has recently been tested in 
Parkinson’s diseases models, where it was demonstrated to attenuate dopaminergic 
neuronal cell death.  In this study, we examined the neuroprotective effects of PQQ in 
primary cultures of rat cerebellar granule neurons. We showed that PQQ displayed a 
protective effect against hydrogen peroxide- and copper chloride-induced oxidative 
stress. Conversely, we report that PQQ did not exhibit any protection against 
excitotoxicity, nitrosative stress, and caspase-dependent intrinsic apoptosis in cultured 
neurons. These data indicate that PQQ has a dramatic neuroprotective effect, which is 
specific to oxidative stress. This is an important finding as oxidative stress believed to be 
a common underlying factor of several neurodegenerative diseases.  We conclude that 
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PQQ is a promising candidate for testing in preclinical models of neurodegeneration and 
may represent a novel therapy for the treatment of neurodegenerative disorders for which 
oxidative stress has been implicated as a causative factor. 
 
4.2. Introduction 
Neurodegenerative is a term from two words; neuro referring to nerves cells and 
degenerative referring to progressive damage of the function and structure of neurons.  
Neurodegenerative diseases include Parkinson’s disease (PD), Alzheimer’s disease (AD), 
and amyotrophic lateral sclerosis (ALS).  Age associated with increased risk of 
neurodegenerative diseases. These diseases have an average onset of 50-70 years (Martin, 
1999).  However, patients with the familial forms of neurodegenerative disorders may 
suffer from a much earlier onset of diseases (Martin, 1999).   In many cases patients 
present with a sporadic form of the degenerative disorder with no known genetic 
component (e.g 90-95% sporadic in ALS; Thomas and Beal, 2007; Ferraiuolo et al., 
2011; Anand et al., 2013). In both familial and sporadic disorders, neuronal cell death can 
occur through several different pathways, including mitochondrial dysfunction, oxidative 
stress, excitotoxicity, and/or misfolding of proteins (Ferraiuolo et al., 2011; Chakrabarti 
and Mohanakumar et al, 2016). Because of the complexity of the mechanisms involved, 
there is growing scientific interest in elucidating alternative approaches to cure these 
diseases. For example, several plants and their derivatives have displayed a remarkable 
ability to improve the health of patients who suffer from neurodegenerative diseases 
(Howes et al., 2003). Recent research indicates that the health benefits conferred by plant 
therapy may be related to the pharmacological activities of their constituents, such as 
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antioxidant, anti-inflammatory, pro-survival signaling pathways (i.e., enhancement of the 
Nrf2 and CREB; transcription factor NF-E2-related factor 2 (Nrf2) that regulates the 
expression of antioxidant genes and also cAMP-response element binding protein 
(CREB) the pro-survival protein) (Wu et al., 2010).  
 One of the most abundant types of molecules that is found in plants are 
polyphenols. Polyphenols have received a lot of attention due to their bioavailability and 
recent prospective studies which have shown their benefits in vitro and in vivo (Del Rio 
D et al., 2010).  For instance, polyphenols display anti-apoptotic, antioxidant and anti-
cancer activities (Mercer et al., 2005; Ferguson et al., 2004). In addition, patients with 
neurological disorders have demonstrated an increase in life span after following diet rich 
in polyphenols. Further, long-term treatment with polyphenols delayed the symptoms of 
aging related disorders like ALS (Xu et al., 2006). Since natural compounds have 
different pharmacological properties and may be able to attenuate several common causes 
of neuronal cell death, it is possible that consuming these compounds may represent a 
strong potential therapy for neurodegenerative illness.  
 Pyrroloquinoline quinone (PQQ) is a polyphenolic compound which is 
found naturally in many plants, but with particularly high concentrations in fermented 
soybeans, parsley, and green tea (Kumazawa et al., 1995). Research has provided 
considerable insight into the multiple pro-survival properties of PQQ, and the importance 
of a PQQ-rich diet has been demonstrated in numerous studies. A PQQ-deprived diet 
leads to many physiological problems, such as defects in growth, reproduction, and 
immune system performance (Steinberg et al., 2003; Rucker et al., 2009).  
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 In addition to its physiological activities, PQQ has several biomedical 
activities. For example, PQQ reduced the amount of damage in an animal model of 
cardiac ischemia (Rucker et al., 2009). The neuroprotective effects of PQQ have also 
been investigated in countless studies due to its implication in several pro-survival 
pathways. Neuro-inflammation is one of the prominent mechanisms that is thought to 
contribute to neurodegeneration. The anti-inflammatory effect of PQQ has been 
investigated in vitro. Yang et al. (2014) showed that PQQ treatment inhibited the 
production of many inflammatory mediators which were induced by LPS such as, 
inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis 
factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin 6 (IL-6). Moreover, PQQ 
showed protective effects against oxidative stress, another molecular pathway that is 
consistently implicated in the etiology of neurological disorders (Nunome et al., 2008). 
This effect of PQQ may be related to its ability to act as a free radical scavenger or its 
ability to enhance Nrf2, thereby upregulating antioxidant genes (Zhang et al., 2012; 
Nunome et al., 2008). In addition, aggregation of β-amyloid (Aβ) is potentially one of the 
critical causes of Alzheimer’s disease (AD), and has been alleviated by treatment with 
PQQ (Zhang et al., 2009). Interestingly, PQQ can also induce mitochondrial biogenesis, 
and diets lacking PQQ have been shown to decrease the number of mitochondria 
(Chowanadisai et al., 2010).  In models of PD and stroke, PQQ attenuated neuronal death 
(Qin et al., 2015: Jensen et al., 1994).  
 The purpose of the present study is to investigate the neuroprotective 
effect of PQQ against different insults which activate neuronal death pathways. We pre-
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incubated cerebellar granule neurons (CGNs) with PQQ (Fig. 4.1), and subsequently 
treated the neurons with different toxic insults. The percentage of apoptosis was 
measured by immunocytochemistry designed to visualize the microtubule network and 
nuclear morphology. Our data demonstrate that PQQ displays significant neuroprotective 
effects against two different neuronal insults which induce cell death via oxidative stress. 
Conversely, PQQ failed to protect against insults that cause nitrosative stress, apoptosis, 
and excitotoxicity. Based on our findings, PQQ may be a promising therapy for 




































4.1. Materials.   
Hoechst dye, paraformaldehyde, glutamic acid, and glycine were purchased from 
Sigma Aldrich (St. Louis, MO). Sodium nitroprusside (SNP) was obtained from 
Calbiochem (San Diego, CA). Stock solutions of glutamate/glycine were made in sterile 
water. Pyrroloquinoline quinone (PQQ) and copper chloride (CuCl2) were obtained from 
Sigma Aldrich (St. Louis, MO).  
 
4.2. Cell culture.  
Cerebellar granule neurons (CGNs) were isolated from 7-day-old Sprague-
Dawley rat pups (15-19g) of both sexes as described previously (Linseman et al., 2001). 
Briefly, neurons were plated on poly-L-lysine-coated culture dishes at a density of 
2.0x106 cells/mL in Basal Modified Eagle’s medium (BME) containing 10% fetal bovine 
serum, 25 mM potassium chloride (KCl), 2 mM L-glutamine, penicillin (100units/ml)-
streptomycin (100µg/ml; Life Technologies, Inc., Gaithersburg, MD). Cytosine 
arabinoside (AraC, final concentration of 10µM) was added after 24h to limit the growth 
of non-neuronal cells. With this protocol, the purity of cerebellar granule neurons was 
~95-99%. After 6 or 7 days in culture, CGNs were rinsed two times in serum-free culture 
medium containing 25mM depolarizing potassium (25K-Serum) and maintained in the 
same medium for pre-incubation with pyrroloquinoline quinone (PQQ; 10 nM, 30nM, 
100nM, 300nM, and 1 μ M) for 24h. Apoptosis was induced either by removal of 
depolarizing extracellular potassium (5mM KCl; 5K apoptotic condition), or by the direct 
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addition of the following stressors: (1) sodium nitroprusside (SNP; 50µM) to induce 
nitrosative stress, (2) 100µM glutamate and 10µM glycine (Glu/Gly) to induce 
excitotoxicity, (3) hydrogen peroxide (H2O2; 1mM), or (4) copper chloride (CuCl2) 
(70µM). Pre-treated cells were treated overnight for approximately 16-18h with each 
stressor.  
4.3. Fixation and Hoechst Staining  
Following treatment, CGNs were washed once with phosphate buffered saline 
(PBS; pH=7.4) and fixed for one hour at room temperature in 4% paraformaldehyde. 
Cells were washed again with PBS and Hoechst stained at a concentration of 10µg/ml. 
After a minimum of one hour, cells were imaged using a Zeiss Axiovert-200M epi-
fluorescence microscope. Five images were taken per well to assess apoptosis, with either 
duplicate or triplicate wells per experiment. Cells were counted and scored as either 
living or apoptotic based on nuclear morphology using images showing decolorized 
Hoechst fluorescence. CGNs displaying condensed or fragmented nuclei were counted as 
apoptotic. 
4.4. Statistical Analysis.  
Every experiment was performed using either duplicate or triplicate wells for each 
treatment, with each experiment being performed at least three times. Data are 
represented as the means +/- SEM of the total number of experiments. Data have 
analyzed using a one-way ANOVA with a post hoc Tukey’s test. A p-value of <0.05 was 





4.1. PQQ protects CGNs from oxidative stress induced by hydrogen peroxide.   
Oxidative stress occurs as a consequence of an imbalance between free radical 
and antioxidant molecules (Uttara et al., 2009), resulting in neuronal cell death. 
Treatment with hydrogen peroxide (H2O2) is a common model to study oxidative stress 
(Fatokun et al., 2007). To assess the neuroprotective effects conferred by PQQ, CGNs 
were pre-incubated with different concentrations of PQQ (10 nM, 30nM, 100nM, 300nM, 
and 1 μM) for 24h. Next, pre-treated CGNs were treated with or without H2O2 (1 mM) 
for an additional 16-18h. To evaluate neuronal injury induced by H2O2 in CGNs, we first 
examined the nuclear morphology. Compared to control cells, H2O2 caused dramatic 
damage to nuclei.  Nuclei were considered as apoptotic if fragmented or condensed as 
assessed by Hoechst staining (Fig 4.2A left panels). It is also evident through the bright 
field images that the neuronal processes were also destroyed by H2O2. Importantly, these 
effects were largely reduced by PQQ in a concentration dependent manner.  
Quantification of these data presented as the percentage of apoptotic cells counted using 
decolorized Hoechst fluorescence (Fig. 4.2B) to assess nuclear morphology. By this 
method, it was found that PQQ significantly decreased cell death in a dose-dependent 
manner, particularly at a concentration of 100nM, 300nM, and 1μM. However, lower 






Figure 4.2. PQQ protects CGNs from oxidative stress induced by hydrogen 
peroxide. (A) CGNs were pre-incubated for 24h in serum-free culture medium 
containing 25mM KCl (Control; Con) alone or with one of five different 
concentrations of PQQ (10nM, 30 nM, 100nM, 300nM, and 1 μM) individually. 
Cells were then incubated for an additional 16-18h with hydrogen peroxide (H2O2; 1 
mM). Following incubation, CGNs were fixed and Hoechst stained. (B) Quantitative 
assessment of cellular apoptosis for CGNs in untreated controls, 1 mM H2O2 
concentration, and 1mM H2O2 plus 10nM, 30 nM, 100nM, 300nM, or 1μM PQQ. 
Cells were quantified by counting them as either living or apoptotic based on 
nuclear morphology, and the percent of cells showing apoptotic nuclei (either 
condensed or fragmented morphology) was determined. Data are expressed as the 
mean +/- SEM, n=4. *** indicates p<0.001 compared to control, ### indicates 
p<0.001 compared to H2O2 alone, and # indicates p<0.05 compared to H2O2 alone as 




4.2. PQQ protects CGNs from oxidative stress induced by copper chloride. 
 In addition to H2O2, we also tested the oxidative stressor, copper chloride 
(CuCl2) (Hu et al., 2016). CGNs were pre-incubated with PQQ (100nM, 300nM, and 1 
μM) and subsequently treated for a further 16-18h with CuCl2 (final concentration; 
70µM). Nuclear morphology was assessed by Hoechst staining. Nuclei were fragmented 
or condensed following exposure to CuCl2 (Fig. 4.3A). However, pre-incubation with 
each concentration of PQQ significantly reduced oxidative damage and diminished the 
appearance of apoptotic nuclei (Fig. 4.3A, left panels). These data show that PQQ is 
capable of protecting CGNs from CuCl2-induced oxidative stress. The percentage of 
apoptotic cells was determined for each treatment, and the quantitative results are shown 
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Figure 4.3. PQQ protects CGNs from oxidative stress induced by copper chloride. 
(A) CGNs were pre-incubated for 24h in serum-free culture medium containing 
25mM KCl (Control; Con) alone or with one of five different concentrations of PQQ 
(10nM, 30 nM, 100nM, 300nM, or 1 μM). Cells were then incubated for an 
additional 16-18h with copper chloride (CuCl2; 70 μM). Following incubation, 
CGNs were fixed and Hoechst stained.  (B) Quantitative assessment of cellular 
apoptosis for CGNs in untreated controls, 70μM CuCl2, and 70μM CuCl2 plus 
10nM, 30 nM, 100nM, 300nM, and 1 μM PQQ. Cells were quantified by counting 
them as either living or apoptotic based on nuclear morphology, and the percent of 
cells showing apoptotic nuclei (either condensed or fragmented morphology) was 
determined. Data are expressed as the mean +/- SEM, n=4. *** indicates p<0.001 
compared to control, ### indicates p<0.001 compared to CuCl2 alone, and # 
indicates p<0.05 compared to CuCl2 alone as determined using one-way ANOVA 




4.3. PQQ did not protect CGNs from excitotoxicity, nitrosative stress, or caspase 
activation. 
 Next, we examined the neuroprotective effect of PQQ against other death 
pathways induced by glutamine/glycine, sodium nitroprusside (SNP), and 5K medium.   
Extracellular glutamate mediates excitotoxicity by allowing calcium to enter and 
depolarize the cell. This prolonged increase in intracellular calcium leads to the formation 
of ROS and in turn, neuronal death (Arundine and Tymianski 2003). To modulate the 
previous death pathway, we added glutamine/glycine (100μM/10μM). We induced 
nitrosative stress by adding SNP (50 μM), the nitric oxide donor. Moreover, we enhanced 
caspase activation by modifying the potassium level in CGN medium. CGNs were pre-
incubated with PQQ (1 μM) and then treated for a further 16-18h with glutamine/glycine 
(100μM/10μM), SNP (50 μM), or exposure to 5K apoptotic medium consisting of low 
potassium conditions (5K medium). Unexpectedly, pretreatment with PQQ (1 μM) did 
not show any protection against the previous insults and stressors. The percentage of 
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Figure 4.4. PQQ did not protect CGNs from excitotoxicity, nitrosative stress, or 
caspase activation by glutamate/glycine, SNP, or 5K medium, respectively. CGNs 
were pre-incubated for 24h in serum-free culture medium containing 25mM KCl 
(Control; Con) alone or with one of five different concentrations of PQQ (10nM, 30 
nM, 100nM, 300nM, or 1 μM). Cells were then incubated for an additional 16-18h 
with glutamate/glycine (100μM/10μM), SNP (50 μ M), or the low potassium medium 
was removed. Quantitative assessment of cellular apoptosis for CGNs in untreated 
controls, glutamate/glycine, SNP and 5K medium, and glutamine/glycine, SNP and 
5K medium plus 10nM, 30 nM, 100nM, 300nM, and 1 μM PQQ. Cells were 
quantified by counting them as either living or apoptotic based on nuclear 
morphology, and the percent of cells showing apoptotic nuclei (either condensed or 
fragmented morphology) was determined. Data are expressed as the mean +/- SEM, 
n=4. *** indicates p<0.001 compared to control, ### indicates p<0.001 compared to 
glutamine/glycine, SNP and 5K medium alone, and # indicates p<0.05 compared to 
glutamine/glycine, SNP and 5K medium alone as determined using one-way 









 PQQ has many pro-survival properties such as antioxidant, anti-cancer, and anti-
inflammatory activities. In addition, PQQ has a unique ability for inducing mitochondrial 
biogenesis. In the present study, we assessed the neuroprotective effects of PQQ against 
different molecular cell death pathways that we modulated by exposure to several 
stressors in cultured rat CGNs, an established model to study neuronal cell death 
(Maycotte et al., 2010). An examination of five different cell stressors revealed that PQQ 
showed a significant protection against insults that are known to induce oxidative stress 
(H2O2 and CuCl2). However, PQQ failed to protect CGNs from other mechanisms that 
prompt neuronal death including nitrosative stress, excitotoxicity, and caspase activation. 
Oxidative stress is one of the mechanisms that leads to neuronal death, disturbing the 
balance between ROS (e.g., H2O2) and antioxidants, ultimately underlying biological 
aging (Yang et al., 2015).  
 The neuroprotective effects of PQQ against H2O2 are hypothetically 
interrelated with its ability to scavenge free radicals, in addition to its other properties, 
such as upregulation of the pro-survival protein Bcl-2, which is known to prevent the 
release of mitochondrial cytochrome c that promotes cell death (Yang et al., 2015). Our 
findings are similar to Yang et al. (2015), who demonstrated that PQQ alleviated the 
oxidative stress induced by H2O2 and that PQQ modulated mitochondria to protect cells 
from death (Yang et al., 2015). Taken together, our present findings in conjunction with 
previous studies, suggest that PQQ possesses a neuroprotective effect against oxidative 
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stress and may represent a novel therapy for the treatment of neurodegenerative 
disorders.   
There is not a lot of research examining the effects of PQQ on CuCl2; however, 
other studies have used another insult to induce oxidative stress which is 6-
hydroxydopamine (6-OHDA) (Nunome et al. 2008). Similar to our data utilizing another 
oxidative stress promoter, PQQ protected cells from this oxidative stressor (Nunome et 
al. 2008).  The neuroprotective effects of PQQ against nitrosative stress induced by SNP, 
the NO donor have been examined. Our data indicate that PQQ does not protect cells 
from nitrosative stress.  Currently, other studies corroborating our findings are lacking.  
Since it has been confirmed that excitotoxicity plays an important role in 
neurodegenerative disorders, we also examined the protective effects of PQQ against 
insults known to induce excitotoxic neuronal cell death. To induce excitotoxicity, we 
treated cells with glutamate/glycine following pretreatment of CGNs with PQQ. 
However, treatment with PQQ did not show any protection. These data are in contrast 
with a study by Aizenman et al., demonstrating that PQQ attenuates the activation of 
NMDA receptor to mediate in excitotoxicity in both cortical neurons and astrocytes 
(Aizenman et al., 1992). This difference in experimental results may be correlated to 
using different cell types or to the higher concentration of glutamate/glycine used in their 
study. 
 The anti-apoptotic properties of PQQ have also been demonstrated in a 
study by Lu et al. (2015), demonstrating that pretreatment with PQQ in an intracerebral 
hemorrhage rat model, decreased caspase activation. The authors also reported that PQQ 
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protected rats from apoptosis by increasing the ratio of the pro-survival protein Bcl-2 to 
the pro-apoptotic protein Bax.  
 As an additional stressor to evaluate the protective effects of PQQ, we 
activated the intrinsic apoptotic pathway by treating with 5K apoptotic medium, leading 
to potassium deprivation by removing the optimum level of potassium required by CGNs.  
Under that condition of deprivation (5K medium), PQQ didn’t protect CGNs from 
apoptosis.  Thus, it appears that PQQ is specifically protective against oxidative stress in 
CGNs. 
 On the whole, our data support the neuroprotective effect of PQQ against 
two distinct inducers of oxidative stress. Nevertheless, PQQ did not show any 
neuroprotection against other neuronal death pathways (i.e., nitrosative stress, 
excitotoxicity, or intrinsic apoptosis). This finding provides substantial vision into PQQ 
as a potential therapy for neurodegenerative disorders. After the successful result by 
testing PQQ in pre-clinical disease models of Parkinson disease (Qin et al., 2015), it’s 
noteworthy to consider PQQ as a novel therapeutic option to treat patients with 








CHAPTER FIVE: CONCLUSIONS AND FUTURE DIRECTIONS  
     Caffeic acid is a broad compound among chlorogenic acid and the two 
other metabolites (Ferulic acid and quinic acid) that showed protection against 
multiple insults and stressors in vitro. Results show promising therapeutic 
possibilities and pre-clinical testing, as caffeic acid phenethyl ester (CAPE) has 
been shown to delay and decrease the hallmark symptoms in mouse and rat 
models of Parkinson’s disease (Fontanilla et al., 2011). CAPE also delays the 
death in a mouse model of amyotrophic lateral sclerosis (Fontanilla et al., 2012). 
Since CAPE hydrolyzes to caffeic acid, and is the principle CAPE metabolites, 
further research on caffeic acid would give similar results as CAPE. Therefore, it 
was decided to not invest in more studies with caffeic acid. 
     Rosmarinic acid and carnosic acid showed a significant protective 
effect from nitrosative stress.  Moreover, rosmarinc acid and carnosic acid 
protected CGNs from excitotoxicity and caspase activation-induced apoptosis, 
respectively. Furthermore, both compounds showed an increased survival in 
different models of neurodegenerative diseases. Rosmarinic acid caused a 
noticeable decrease in motor neuron death in a mouse model of ALS. Also, 
carnosic acid extended the survival of an Alzheimer’s disease mouse model. We 
believe that more investigation with other models would prove valuable to study. 
Since both compounds protected CGNs through different pathways, further 
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studies that look at the synergistic properties of the combined compounds may be 
a promising therapy for neurodegenerative disorders.   
       PQQ protected CGNs from oxidative stress induced by two insults, 
hydrogen peroxide and copper chloride, even with very low concentrations of 
PQQ. These data are promising in vitro, and encourage further study into the 
mechanisms by which PQQ protects CGNs from these two insults. The ability of 
PQQ to induce mitochondrial biogenesis and also induce the nerve growth factor 
(NGF) has been demonstrated by several studies. Our future studies will examine 
the involvement of mitochondria biogenesis on the protective effects of PQQ by 
inhibiting PGC-1α, a key transcriptional regulator of mitochondria biogenesis. We 
also plan to investigate the protection mechanisms, and if they depend on PQQ 
activity for promoting NGF expression. PQQ showed a significant improvement 
in pre-clinical disease models of Parkinson diseases. Further pre-clinical studies 
with another model of neurodegenerative diseases, such as ALS mice, would be 
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APPENDIX A: ABBREVIATIONS 
6-OHDA; 6-hydroxydopamine  
AChE; acetylcholinesterase  
AD; Alzheimer’s disease  
ALS; amyotrophic lateral scelorosis 
Bcl-2; B cell lymphoma protein 2 
AMPA; α – Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ARE; Antioxidant Response Element  
BChE; butyrylcholinesterase 
Bcl-2; B-cell lymphoma 2 
BME; Basal Modified Eagle’s medium 
CA; caffeic acid 
Ca2+; calcium 
CAPE; caffeic acid phenethyl ester  
CAR; Carnosic acid  
CGA; chlororgenic acid 
CGN; cerebellar granule neuron 
CNS; central nervous system 
COX-2; cloxygenase-2  
CREB; cyclic AMP response element binding protein 
DMSO; dimethylsulfoxide 
EAAT2; excitatory amino acid transporter 2  
EGCG; epigallocatechin 3-gallate  
ER; Endoplasmic reticulum  
ERAI; ER stress-activated indicator  
FA; ferulic acid 
FDA; Food and Drug Administration  
FIM; Foundation for Innovation in Medicine  
Glu/Gly; glutamate/glycine 
GluRdelta2; excitatory amino acid receptor delta2  
GPx1; glutathione peroxide 1  
GST; glutathione S-transferase 
h; hours 
H2O2; hydrogen peroxide 
hiPSC; human induced pluripotent stem cells  
HIV; human immunodeficiency virus  
 HO-1; heme oxygenase-1  
hRSV; human respiratory syncytial virus  
Hsp70; heat shock protein  
IFN-γ; interferon gamma  
IL-1β; Interleukin 1 beta 
IL-6; Interleukin 6 




MPTP; methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine  
NMDA; N-Methyl-D-aspartate  
nNOS; neuronal NO synthase  
NO; nitric oxide 
NF-κB; nuclear factor kappa-light-chain-enhancer of activated B cells transcription factor 
NQO1; NADH-quinone oxidoreductase 1  
Nrf2; NF-E2-related factor-2 
O2
-; superoxide 
PBS; phosphate buffered saline 
PC12; rat pheochromocytoma adrenal medulla cell line 
PCD; programmed cell death 
PD; Parkinson’s disease  
PGC-1 α; peroxisome proliferator-activated receptor-ɣ coactivator-1α  
PI3K; phosphoinositide 3-kinase 
PQQ; Pyrroloquinoline quinone  
QA; quinic acid  
RNS; reactive nitrogen species  
ROS; reactive oxygen species 
ROS; Rosmarinic acid  
SNP; sodium nitroprusside 
SOD1; super oxide dismutase 1  
SOD2; super oxidative dismutase 2  
TNFα; Tumor necrosis factor 
TRAIL; TNF-related apoptosis-inducing ligand 
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